Systematic review with Qualitative Assessment of Antidepressant Monotherapies in Patients with Major depressive Disorder with an inadequate response to a prior SSRI or SNRI (Englisch)
- Neue Suche nach: Brignone, M.
- Neue Suche nach: Painchault, C.
- Neue Suche nach: Diamand, F.
- Neue Suche nach: Brignone, M.
- Neue Suche nach: Painchault, C.
- Neue Suche nach: Diamand, F.
In:
VALUE IN HEALTH
;
18
, 3
;
A116
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Systematic review with Qualitative Assessment of Antidepressant Monotherapies in Patients with Major depressive Disorder with an inadequate response to a prior SSRI or SNRI
-
Beteiligte:
-
Erschienen in:VALUE IN HEALTH ; 18, 3 ; A116
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:A116
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 18, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A1
-
OUTCOMES AND HEALTH RESOURCE UTILIZATION AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AT AN ACADEMIC MEDICAL CENTER (AMC) IN THE UNITED STATESBress, A. / King, J. / Singhal, M. / Brixner, D. / Kielhorn, A. / Patel, H. / Maya, J. / Biskupiak, J. / Munger, M. et al. | 2015
- A2
-
Differences in Mastectomy Rates Based on Hormone Receptor Status in Early Stage Tumors: A Seer Database AnalysisHinyard, L. / Schwartz, T. et al. | 2015
- A3
-
The Effect Of Cost-Related Medication Nonadherence On The Decision Of Taking Up Medicare Part D Among Elderly Medicare BeneficiariesHan, Y. / Balkrishna, R. et al. | 2015
- A4
-
Economic Value Of Improved Accuracy For Self-Monitoring Of Blood Glucose Devices For Type 1 DiabetesMcQueen, R. / Breton, M. / Ott, M. / Koa, H. / Beamer, B. / Campbell, J. D. et al. | 2015
- A5
-
A Comparative Cost Utility Analysis For First Line Treatment Of Metastatic Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Exon 19 Deletions Or Exon 21 (L858r) Substitution MutationsCarlson, J. J. / Slejko, J. F. / Goertz, H. / Veenstra, D. L. et al. | 2015
- A6
-
Life At A Premium: Considering An End-Of-Life Premium In Value-Based ReimbursementMcCabe, C. / Paulden, M. / O’Mahony, J. F. / Edlin, R. / Culyer, A. J. et al. | 2015
- A7
-
A Review And Update To The Guidance Document For The Costing Process In The Canadian Health Care SettingBudden, A. J. / Lee, K. / Jacobs, P. et al. | 2015
- A8
-
Systematic Review Of Cost Effectiveness Of Ultra-Orphan Therapies: Lesson Learned From Published Htas And StudiesAggarwal, S. / Topaloglu, H. / Kumar, S. et al. | 2015
- A9
-
Patient Versus General Population Preferences In Anticoagulant TherapyNajafzadeh, M. / Gagne, J. J. / Choudhry, N. K. / Polinski, J. / Avorn, J. L. / Schneeweiss, S. et al. | 2015
- A10
-
Getting The Full Picture: The Importance Of Exrapolating Beyond The DataAl-Mutairi, R. / Rittenhouse, B. et al. | 2015
- A11
-
Usage Of Propensity Score, Instrumental Variable, Or Machine Learning For Real World Data AnalysisChoi, S. et al. | 2015
- A12
-
Combining Mcda With Advanced Statistics To Tackle Challenges Of Data And Judgment Uncertainty: Case Study Of Safety AssessmentsGoetghebeur, M. M. / Wagner, M. / Nikodem, M. / Zyla, A. / Micaleff, A. / Amzal, B. et al. | 2015
- A13
-
Statistical Identification Of Patient Selection Bias In Retrospective Chart ReviewsSignorovitch, J. E. / Reichmann, W. M. / Li, N. / Liu, Z. / Hao, Y. / Perez, J. R. et al. | 2015
- A14
-
Review of cost-effectiveness analyses of varicella vaccination: which model structure assumptions and input parameters matter?Talbird, S. E. / Mauskopf, J. A. / Yang, H. K. et al. | 2015
- A15
-
Suggestion Of New Methods To Calculate Confidence Interval For Incremental Cost-Effectiveness Ratio Which Solve The Issues With Conventional MethodAranishi, T. / Ikeda, S. et al. | 2015
- A16
-
The Cost Of Drug-Related Morbidity That Lead To Emergency Visits In A Brazilian HospitalFreitas, G. / Balbinotto, G. / Hughes, D. / Heineck, I. et al. | 2015
- A17
-
A Virtual Database To Measure Costs Associated With Comorbidities Among Patients With Chronic HcvKawabata, H. / Behl, A. / Hines, P. / Liu, T. / Sill, B. / Hede, S. / Gorsh, B. / Moorthy, V. et al. | 2015
- A18
-
Lack Of Adherence To Immunosuppressive Treatment In Kidney Transplant Patients: Computer Assisted Qualitative Data Analysis (Caqdas) Of An Expert PanelCallejo, D. / Rodríguez-Aguilella, A. / Fernández-Ortiz, L. / González, E. / Toledo, A. / Rebollo, P. / Muduma, G. et al. | 2015
- A19
-
Joint Estimation Of Markov Chain Transition Probabilities Using Survival Models And Constrained Optimization: A Case Study On Diabetes And Mortality And Their Association With Body Mass Index, Age, And GenderWu, S. / Li, J. / Carlsson, N. P. / Leung, M. Y. / Colditz, G. A. / Chang, S. et al. | 2015
- A20
-
Reduction Of Influenza Disease Cost With Suboptimal VaccinationBailey, N. / Wilson, A. / Li, Y. et al. | 2015
- A21
-
Whole-Disease Model Approach: Methodologies And Challenges In Communicating The Economic Burden Of Rare DiseasesShah, A. / Proach, J. et al. | 2015
- A22
-
Contrasting The Relative Risk Reduction Of Cardiovascular Events In The Core Diabetes Model Associated With Single Risk Factor Changes Across Alternative Risk Engines: Ukpds68, Ukpds82 And Swedish National Diabetes Registry EquationsFoos, V. / Lamotte, M. / McEwan, P. et al. | 2015
- A23
-
Development And Validation Of The Hemophilia-Specific Burden Scale For Caregivers Of Children With Hemophilia In The Us – The Hemophilia Associated Caregiver Burden Scale (Hemocabtm)von Mackensen, S. / Wisniewski, T. / Urgo, J. / Boggio, L. et al. | 2015
- A24
-
Does differential framing of opt-out alternatives in discrete choice experiments (dces) matter? Comparison of random utility maximization (rum) and random regret minimization (rrm) modelsChaugule, S. / Hay, J. W. / Young, G. / Martin, O. A. / Drabo, E. F. et al. | 2015
- A25
-
Depression And Quality Of Life Among Individuals With Chronic Obstructive Pulmonary Disease In North IndiaNegi, H. / Raval, A. et al. | 2015
- A26
-
Examining The Relationship Between Health-Related Quality Of Life And Increasing Numbers Of DiseasesRand-Hendriksen, K. / Augestad, L. A. / Whitehurst, D. G. / Barra, M. et al. | 2015
- A27
-
Usability Testing Of The Web-Based Versions Of The Standardised Asthma Quality Of Life Questionnaire For 12 Years And Older (Aqlq(S)+12) And The Asthma Control Questionnaire (Acq-6)Juniper, E. F. / Lambe, J. / Thomas, M. / Arden-Close, E. / Grataloup, G. et al. | 2015
- A28
-
Development Of A Disease Model For Sporadic Inclusion Body Myositis (Sibm)Gnanasakthy, A. / DeMuro, C. / Lewis, S. / Tseng, B. et al. | 2015
- A29
-
Challenges Faced During Linguistic Validation For South AfricaTowns, L. / Williams, H. / Anderson, H. / Gergovich, B. et al. | 2015
- A30
-
Importance Of The Conceptual Definition Of Pro Measures: A Case Study With The Linguistic Validation Of The Irritable Bowel Syndrome Quality Of Life (Ibs-Qol) Instrument In 17 Asiatic LanguagesLambe, J. / Patrick, D. L. / Toraubully, N. / Skerritt, B. / Acquadro, C. et al. | 2015
- A31
-
Alternative Weighting Approaches For Matching Adjusted Indirect Comparisons (Maic)Belger, M. / Brnabic, A. / Kadziola, Z. / Petto, H. / Faries, D. et al. | 2015
- A32
-
Cluster Analysis Of Healthcare Costs Patterns In END STAGE Renal Failure Patients Who Initiated HemodialysisLiao, M. / Li, Y. / Kianifard, F. / Obi, E. / Arcona, S. et al. | 2015
- A33
-
Response Rates In Direct-To-Patient SurveysGoolsby Hunter, A. / Brenneman, S. et al. | 2015
- A34
-
An Analytical Criterion For Judging The Extended Dominancy Of A New Technology Compared To The Standard Of Care And Placebo ControlKamae, I. / Sugimoto, T. / Yamabe, K. et al. | 2015
- A35
-
Advancing Methods Of Hta: Optimising Monitoring Tests To Meet Value TargetsMcCabe, C. / Paulden, M. / Akude, P. et al. | 2015
- A36
-
Data Cleaning Paper Patient Reported Outcome (PRO) Data Versus Electronic Patient Reported Outcome (EPRO) DataRoss, J. / Holzbaur, E. / Wade, M. / Rothrock, T. et al. | 2015
- A37
-
Major and minor adverse events in patients were subjected in Cardiac Rhythm Management Devices (CRMD’s) Therapy and their financial implication: a prospective single-center two years SurveyFanourgiakis, J. A. / Simantirakis, E. / Kanoupakis, E. / Chrysostomakis, S. / Chlouverakis, G. / Vardas, P. et al. | 2015
- A38
-
Time-dependence of first appropriate Therapy in primary prevention implantable cardioverter defibrillator patients: is device replacement necessary in patients without prior ICD interventions?Kanoupakis, E. / Fanourgiakis, J. A. / Kallergis, E. / Mavrakis, H. / Maragoudakis, S. / Vernardos, M. / Chlouverakis, G. / Vardas, P. et al. | 2015
- A39
-
Examination of interval incidence of Colorectal Cancer (CRC) at subsequent colonoscopy over time: population-based retrospective cohort studyRen, J. / Asche, C. V. / Kirkness, C. S. / Puli, S. et al. | 2015
- A40
-
The use of Ultrasonic Energy in mastectomy and Lumpectomy procedures: a budget impact analysisOndrejicka, D. A. / Goldstein, L. J. et al. | 2015
- A41
-
Impact of sample collection method for EGFR mutation testing: results of Blood-based and Tissue-based Cobasâ® EGFR mutation testing in the treatment of locally advanced or metastatic NSCLC in the USPoulios, N. / Hristova-Neeley, D. / Gavaghan, M. et al. | 2015
- A42
-
Economic impact of open mechanical stapling vs. manual suturing in ileocolic anastomosis in Mexican Public Healthcare InstitutionsZanela, O. O. / Cabra, H. A. / Sanchez, D. et al. | 2015
- A43
-
A System dynamics model for the cost-effectiveness evaluation of Bacterial whole-genome sequencing for detecting and monitoring outbreaks of MRSAAgirrezabal, I. / Buchanan-Hughes, A. M. / Eddowes, L. A. / Luheshi, L. M. / Sagoo, G. S. / Török, M. E. et al. | 2015
- A44
-
Cost-effectiveness analysis of External looping recording compared to holter monitoring for Syncope in ColombiaOrozco, J. J. / Shrivastav, M. / Vilendrer, S. et al. | 2015
- A45
-
Cost-utility of repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for treatment-resistant depressionGordon, L. G. / Nguyen, K. et al. | 2015
- A46
-
Screening high-risk populations for Latent Tuberculosis: a systematic review of cost-utility analysesCampbell, J. R. / Marra, F. et al. | 2015
- A47
-
Patient’s preferences for dry powder inhaler attributes in Asthma and Chronic Obstructive Pulmonary Disease: a discrete choice experimentHawken, N. A. / Aballéa, S. / Torvinen, S. / Plich, A. / Toumi, M. et al. | 2015
- A48
-
A Framework for coverage decisions for Digital Health TechnologiesWaterman, J. / Taggart, C. / Garfield, S. et al. | 2015
- A49
-
The rise of the value analysis committee at Us Hospitals, better or worse for medical device companies?Hristova-Neeley, D. / Armstrong, S. / Garfield, S. / Ertel, D. et al. | 2015
- A50
-
Effects of Autologous fat grafting systems on inpatient operating room time and costs: a Hospital budget impact analysisLee, L. J. / Xu, S. J. / Mencer, M. / Macarios, D. / Nahabedian, M. Y. et al. | 2015
- A51
-
Hemostasis efficacy of evarresttm compared to Tachosil® in Liver and other Surgical Bleeding: an indirect comparisonCorral, M. / Jamous, N. / Ferko, N. / Bourque, M. et al. | 2015
- A52
-
Comparative outcomes of Testosterone therapy versus no Treatment in hypogonadic menNoone, J. / Blanchette, C. M. / Van Doren, B. A. / Zacherle, E. et al. | 2015
- A53
-
Anti-Diabetic Drugs and the risk of Dementia Among Medicare Beneficiaries with diabetesYuan, J. / Lu, K. et al. | 2015
- A54
-
Real-world canagliflozin utilization: Impact on glycemic control in Patients with Type 2 diabetes mellitusMeckley, L. M. / Miyasato, G. / Kokkotos, F. / Bailey, R. A. et al. | 2015
- A55
-
Metformin and Intensive lifestyle intervention for pre-diabetes - systemati Review of EfficacyFujii, R. K. / Junqueira, M. / Restrepo, M. / Turatti, L. A. et al. | 2015
- A56
-
Efficacy And Safety of Canagliflozin among Patients with type 2 diabetes Mellitus: a Systematic review and meta-analysisKaur, K. / Likhar, N. / Dang, A. et al. | 2015
- A57
-
Temporal Trend and Prevalence of Ckd Stages (Kdigo 2012) in Us Adults with Type 2 Diabetes Mellitus and demographic Subgroups: Nhanes 2007-2012Wu, B. / Bell, K. / Kern, D. M. / Tunceli, O. / Willey, V. / Vupputuri, S. / Stanford, A. / Kalsekar, I. et al. | 2015
- A58
-
Modeling the Long Term Economic Benefits of a Patient-Adjusted Mealtime Insulin Titration Algorithm among Patients with Type 2 diabetes in the united StatesNumapau, N. O. / Murphy, D. R. / Curtis, B. H. / Gahn, J. C. / Curtis, S. / Perk, S. / Yu, X. / Smolen, H. J. et al. | 2015
- A59
-
Estimating Clinical and Economic Outcomes Following a Diabetes-Related vascular ComplicationPerk, S. / Murphy, D. R. / Gahn, J. C. / Yu, X. / Smolen, H. J. et al. | 2015
- A60
-
Diabetes Mellitus Treatment: Cost-Effectiveness of Schemes Therapeutic Glargine and Nph - Brazil, 2014Alvares, J. / Almeida, A. M. / Faleiros, D. / Araujo, V. E. / Guerra Junior, A. A. / Acurcio, F. d. et al. | 2015
- A61
-
Cost-effectiveness Analysis of second-Line and third-Line antidiabetic Drugs In Tyep 2 Diabetes: an Empirical, population-based observational Study From TaiwanOu, H. T. / Balkrishnan, R. / Yang, C. Y. / Chang, K. C. et al. | 2015
- A62
-
The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canadaTeschemaker, A. / Neslusan, C. / Sabapathy, S. / Yoong, K. / Johansen, P. / Willis, M. et al. | 2015
- A63
-
Impact of a Pharmacist telephone Intervention on Preventing Medication discontinuation among Hypertensive Patients With Diabetes In a Medicare advantage planWang, X. / Serna, O. / Henges, C. / Essien, E. J. / Chung, N. / Fleming, M. / Abughosh, S. et al. | 2015
- A64
-
Validation of Prescription Medication Adherence prediction Tool (Rxapt) to Predict non-Adherence among Diabetes Patients Enrolled in medicareMhatre, S. / Sansgiry, S. / Serna, O. et al. | 2015
- A65
-
Engaging Patients With E-Clinical Technology: Incorporating Patient Preferences Into Diabetes Clinical Trials And CareKhurana, L. / Gary, S. T. / Vazquez, V. / Otero, A. / Evans, C. / Dallabrida, S. et al. | 2015
- A66
-
Growth Hormone deficiency in Pediatrics: Concept Elicitation To Support The Development of Child Pro And Parent Obsro MeasuresBrod, M. / Håkan-Bloch, J. / Hojbjerre, L. / Alolga, S. L. / Nacson, A. / Rasmussen, M. H. et al. | 2015
- A67
-
Depression Treatment and Health-Related quality of Life among adults with Diabetes and depressionAlenzi, E. / Sambamoorthi, U. et al. | 2015
- A68
-
Comparative Persistency with Newer agents used to Treat Type 2 Diabetes (T2dm) In the united states: canagliflozin Versus Dipeptidyl Peptidase-4 (Dpp-4) Inhibitors and Glucagon-Like Peptide-1 (Glp-1) agonistsDiels, J. / Neslusan, C. et al. | 2015
- A69
-
Financing a Cure for Diabetes In a multi-Payer environmentBasu, A. / Kamal-Bahl, S. / Subedi, P. et al. | 2015
- A70
-
Changes In Baseline Comorbidities, Medications And Healthcare Costs for A Population of Patients With New-Onset Type 2 Diabetes (T2d) In 2007 Compared With 2012Weng, W. / Liang, M. / Kimball, E. / Hobbs, T. / Kong, S. / Bouchard, J. / Sakurada, B. et al. | 2015
- A71
-
Preparation of a dataset for analysis to develop a predictor Algorithm for Disease State ManagementLovett, A. W. / Chaturvedula, A. / Mukherjee, K. / Brar, A. / Tamhankar, N. et al. | 2015
- A72
-
The impact of the essential Medicine policy on patients’ Health Care Utilization and cost in Tianjin China: a quasi-experimental DesignDing, L. / Wu, J. et al. | 2015
- A73
-
Analysis of the Drug price reviews performed by the Canadian Patented Medicine Prices review Board (1998-2014)Alsumali, A. / Seoane-Vazquez, E. / Eguale, T. / Mekary, R. et al. | 2015
- A74
-
Orphan and Ultra-Orphan Technologies in the new era of payment reform: United States payer perceptionsHogue, S. / Brogan, A. P. / Croft, E. et al. | 2015
- A75
-
FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval PathwayMacaulay, R. et al. | 2015
- A76
-
Developing Algorithms for identifying beneficiaries with higher than expected Utilization of opioids AnalgesicsVerma, D. / Banahan, I. B. / Hardwick, S. P. / Clark, J. P. et al. | 2015
- A77
-
Drug related problems, prescribing pattern and Polypharmacy: evidence from Community Pharmacies in PakistanIqbal, M. S. / Iqbal, M. Z. / Iqbal, M. W. / Akhtar, N. / Bahari, M. B. et al. | 2015
- A78
-
Acountable care Organizations- an Economic solution to provide Quality Healthcare for Medicare PatientsPatel, P. H. et al. | 2015
- A79
-
Impact of cost sharing increases under part D specialty tiers on Biologic adherence and discontinuation among Medicare Beneficiaries with multiple Sclerosis or Rheumatoid ArthritisLi, P. / Hu, T. / Yu, X. / Chahin, S. / Dahodwala, N. A. / Doshi, J. A. et al. | 2015
- A80
-
The Californian Technology assessment forum – the arrival of cost-utility appraisals of Drugs in the USA?Macaulay, R. / Mistry, J. et al. | 2015
- A81
-
Economic impact of waste in Prescribing, Dispensing, and Medication consumption in the United StatesAlmanie, S. A. / Holdford, D. A. et al. | 2015
- A82
-
Impact of the shift to Medicaid managed care on resource Utilization and costs for beneficiaries in Mississippi MedicaidRamachandran, S. / Banahan, I. B. / Hardwick, S. P. / Clark, J. P. et al. | 2015
- A83
-
Cross section analysis of Marginal NHS expenditure by England Health areaHernandez-Villafuerte, K. / Sussex, J. et al. | 2015
- A84
-
Improved Heor writing skills of keen interest to Bio/Pharma Heor Directors and ManagersDrake, T. / Peeples, P. / Smalarz, A. / McClain, B. et al. | 2015
- A85
-
Use of low-cost Generic Programs in a Nationally representative Medicare Population and implications for Quality initiativesPauly, N. / Brown, J. et al. | 2015
- A86
-
An intensive study of adverse events in the Medical Unit of a Nigerian Teaching HospitalOreagba, I. A. / Bada, S. O. / Chuka-Ebene, V. et al. | 2015
- A87
-
The value of otc Medicines in Brazilian Public Health System (SUS)Ferreira, C. N. / Santana, C. F. / Rufino, C. S. et al. | 2015
- A88
-
The effect of Innovation lag on Drug access in TaiwanHsieh, C. / Tasi, Y. / Chiang, Y. / Huang, W. et al. | 2015
- A89
-
A Survey of ispor attendee views on the use of ICER and acceptable ICER thresholdsKaura, S. / Seetasith, A. / Ramesh, V. / Nanavaty, M. / Proach, J. / Khan, Z. M. et al. | 2015
- A90
-
Gender differences in the use of Complementary and Alternative Medicine among Adults with Multiple Chronic conditionsAlwhaibi, M. / Sambamoorthi, U. et al. | 2015
- A91
-
Pharmacy Directors’ perceptions of Administrators’ and Health Professionals’ attitudes towards Collaborative Drug Therapy Management (CDTM) in U.S. hospitalsMishra, P. / Thomas, I. J. et al. | 2015
- A92
-
Perceptions and Knowledge on Antibiotic use and resistance among High School Students and Teachers in New Delhi, IndiaKotwani, A. / Wattal, C. / Siddiqui, Z. / Joshi, P. et al. | 2015
- A93
-
Trend analysis of SMC decisions – what factors influence the likelihood of positive, restricted and negative recommendations?Hill, D. / Marshall, J. D. / Hill, C. A. / Harries, M. et al. | 2015
- A94
-
Trends in Health Technology Assessment (HTA) recommendations from the UK and Germany – a comparison of G-BA, SMC and NICE single Technology appraisal decisionsHill, C. A. / Hill, D. / Marshall, J. D. / Harries, M. et al. | 2015
- A95
-
A Comparison of G-BA’s additional benefit score to NICE ICERsJaksa, A. / Liden, D. / Ho, Y. et al. | 2015
- A96
-
Comparison Of Health Technology Assessment (Hta) Rankings By German And French Hta AgenciesHu, I. / Zheng, J. / Hu, X. H. et al. | 2015
- A97
-
Multiple Chronic Conditions And Bmi: Population Estimates For Health Decision Making In Puerto RicoAmill, A. / Serrano, R. / González, E. / Pérez-Perdomo, R. et al. | 2015
- A98
-
Evaluation Of Knowledge, Attitudes, And Practices Of Healthcare Providers Towards Nutrition Support In PakistanIqbal, M. S. / Bahari, M. B. / Iqbal, M. Z. / Iqbal, M. W. / Nasir, S. et al. | 2015
- A99
-
Irrational drug use pattern in hospitals. A warning for health care systemUmer Jan, S. et al. | 2015
- A100
-
Two-Part Pricing For Patent Protected Medicines †“An Economic Analysis From A Swedish Health Care PerspectiveHertzman, P. G. / Holm, J. et al. | 2015
- A101
-
Comparison Of Machine Learning, Statistical And Hybrid Methods To Identify Predictors Of Positive Treatment Outcomes In Comorbid Conditions Using Emr DataLipkovich, I. / Griner, B. P. / Niemira, J. / Jin, C. et al. | 2015
- A102
-
Augmenting The Regulatory Requirements Of Medication Therapy Management To Improve Program Efficiency And OutcomesMbagwu, G. / Godley, P. et al. | 2015
- A103
-
comparing Medical Therapies For Heavy Menstrual Bleeding Related To Uterine FibroidsYao, X. / Stewart, E. / Laughlin-Tommaso, S. / Borah, B. / Heien, H. et al. | 2015
- A104
-
Factors Affecting Parents’ Knowledge And Practice About Childhood Immunization: Experience From MalaysiaAwadh, A. / Hassali, M. / Al-lela, O. / Bux, S. et al. | 2015
- A105
-
Administration Cost Of Pediatric Vaccination: A Focused Literature ReviewMokiou, S. / de Cock, E. et al. | 2015
- A106
-
Implications Of Employer Coverage Of Contraception: Cost-Effectiveness Of Contraception Under An Employer MandateCanestaro, W. / Vodicka, E. / Downing, D. et al. | 2015
- A107
-
A Systematic Review Of The Use Of The Time Preference Model To Explore Medication Adherence BehaviorMezgebe, M. / Lovett, A. et al. | 2015
- A108
-
Describing Medication Adherence Across A Population: The Value Of Considering Multiple MeasuresAguilar, K. / Hou, Q. / Miller, R. et al. | 2015
- A109
-
Prevalence And Losses In Quality-Adjusted Life Years Of Child Health Conditions: A Burden Of Disease AnalysisCraig, B. / Hartman, J. / Owens, M. / Brown, D. et al. | 2015
- A110
-
Analysis Of Survey Data For Learning Effectiveness Evaluation Of A Talent Management Program For Dairies And FeedlotsBouwer, A. et al. | 2015
- A111
-
A Conceptual Framework For Translating Patient-Reported Outcomes For Implementation In Clinical Practice And Quality Improvement EffortsJeswani, N. / Gaur, P. / Ganesan, N. / Mitchell, K. et al. | 2015
- A112
-
Impact Of Pediatric Regulation On Availability Of Neonate Drug InformationLindberg-Springs, S. / Nambiar, S. / Seoane-Vazquez, E. et al. | 2015
- A113
-
Evaluation Of The Potential Impact Of Drug-Gene Interaction Risk (Dgir) On Health Resource Utilization (Hru)Bress, A. / Unni, S. / Biltaji, E. / Sass, R. / Mamiya, T. / Ye, X. / Yu, B. / Biskupiak, J. / Brixner, D. et al. | 2015
- A114
-
Anticholinergic Medication use and risk of incident Fractures in the elderly with DepressionChatterjee, S. / Aparasu, R. / Carnahan, R. / Chen, H. / Johnson, M. L. et al. | 2015
- A115
-
Antipsychotics for treatment of Pediatric Schizophrenia: a systematic review and network meta-analysis of Symptom control, Weight Gain and discontinuation due to adverse eventsHarvey, R. C. / Shields, G. E. / James, A. C. et al. | 2015
- A116
-
Examining prevalence, incidence and mortality rates among opioid-dependent patients in the U.S. Medicare PopulationLi, L. / Shrestha, S. / Baser, O. / Yuce, H. / Wang, L. et al. | 2015
- A117
-
Socioeconomic status and Depression in JapanTakahashi, O. / Ohde, S. / Deshpande, G. et al. | 2015
- A118
-
Healthcare resource Utilization and costs associated with Paliperidone Palmitate versus oral Atypical Antipsychotics among patients with Schizoaffective DisorderPesa, J. A. / Muser, E. / Montejano, L. B. / Kim, G. / Smith, D. M. et al. | 2015
- A119
-
Healthcare resource Utilization and costs for Schizophrenia Patients initiating asenapine or another branded- atypical Antipsychotic MedicationNguyen, K. / Chitnis, A. / Sun, S. X. / Dixit, S. / Wang, R. / Tawah, A. / Boulanger, L. et al. | 2015
- A120
-
Cost effectiveness analysis of different treatment alternatives in Children with attention deficit hyper activity Disorder (ADHD)El-Hamamsy, M. / Elsayed, B. M. / Eid, E. M. et al. | 2015
- A121
-
Cost-utility of Vortioxetine versus Venlafaxine xr in the treatment of Major depressive Disorder in South KoreaJung, R. / Brignone, M. / Campbell, R. / François, C. / Milea, D. et al. | 2015
- A122
-
Caregivers’ preferences for treatment options in Attention Deficit Hyperactivity Disorder (ADHD): a latent class analysisNg, X. / Bridges, J. F. / Ross, M. M. / Frosch, E. J. / Reeves, G. M. / dosReis, S. et al. | 2015
- A123
-
Factors affecting Health-related Quality of life in individuals with DepressionShah, D. / Anupindi, V. R. / Vaidya, V. / Goodman, M. et al. | 2015
- A124
-
Metareview of findings in Existing Literature reviews covering Behavioral Health-Physical Health Integration StudiesKeleti, D. / Golinkoff, M. / Weaver, K. / Michael, K. E. / Gelzer, A. D. et al. | 2015
- A125
-
Audit of irreversible Monoamine Oxidase Inhibitors (MAOI) prescription for depression in current Clinical practice within the Health improvement Network (THIN) UK primary care databaseO’Leary, C. J. / Nasser, A. / Myland, M. / Waples, S. / Ansell, D. et al. | 2015
- A126
-
Health resource use of Patients enrolled to Janssen connect treated with Long-Acting Injectable (LAI) atypical Antipsychotics: preliminary results from a summative EvaluationBenson, C. / Boulanger, L. / Yang, E. / Pan, X. / Payne, K. / Fastenau, J. et al. | 2015
- A127
-
Use of Clozapine and Antipsychotic Polypharmacy among patients with Schizophrenia: characterizing the prescribersTang, Y. / Horvitz-Lennon, M. / Gellad, W. F. / Normand, S. T. / Donohue, J. M. et al. | 2015
- A128
-
Physician care-providing Behavior in treating Attention-Deficit Hyperactive Children and AdolescentsPatel, A. / Chen, H. / Aparasu, R. / Ochoa-Perez, M. / Chan, W. / Sherer, J. et al. | 2015
- A129
-
A Study of Adverse Drug Reactions Associated With Antihypertensive Agents In A Tertiary Care Teaching Hospital In Central NepalPaudel, S. / Subedi, N. et al. | 2015
- A130
-
Validation Of Hypertensive Patient Identification And Effect Of Varying Observation Time From Administrative Claims Data Using Electronic Medical RecordsLiu, J. / Ma, Q. / Rodenberger, D. / Barron, J. et al. | 2015
- A131
-
Ehealth In The Management Of Chronic Diseases: A Review Of Program EfficacyKiss, N. / Fortier, K. et al. | 2015
- A132
-
The Use Of Low Molecular Weight Heparin And Pneumatic Compression Devises For Deep Vein Thrombosis Prophylaxis In Major Trauma Patients: A Comparative Effectiveness AnalysisAlahmari, A. K. / Almalki, Z. S. / Guo, J. J. et al. | 2015
- A133
-
Evaluation Of Bleeding Outcomes Linked To New Oral Anticoagulants: Review Of The Fda Adverse Event Reporting System (Faers)Jacobs, D. M. / Hempel, C. / Feuerstein, S. et al. | 2015
- A134
-
Physician’s Adherence To Treatment Guidelines In Deep Vein Thrombosis At An Indian Tertiary Healthcare FacilityTiwari, P. / Sunarikani, R. / Malhotra, S. et al. | 2015
- A135
-
Geographic Differences In Availability Of Antihypertensive Medications: A Comparison Of Australia, Canada, Saudi Arabia, Uk, And The UsAlmutairi, H. / Alzarea, A. I. / Seoane-Vazquez, E. / Mekary, R. et al. | 2015
- A136
-
Examining Association Between Liver Enzymes And Lipid Levels Amongst Adults In The United States: A Cross Sectional StudySakharkar, P. / Deb, S. et al. | 2015
- A137
-
Expected Cost Of Drug Therapy In Patients With Arterial Hypertension, Diabetes Mellitus And Dyslipidemia In Chile: A Probabilistic AnalysiSBalmaceda, C. / Espinoza, M. A. et al. | 2015
- A138
-
Acute, Short-Term And Long-Term Costs Of Cardiovascular Events Among Hyperlipidemia PatientsPaoli, C. J. / Gandra, S. R. / Henk, H. J. et al. | 2015
- A139
-
Long-Term Economic Burden Associated With Cardiovascular Events Among High-Risk Patients With HyperlipidemiaFox, K. M. / Wang, L. / Gandra, S. R. / Quek, R. G. / Li, L. / Baser, O. et al. | 2015
- A140
-
Cost-Efectiveness Of Dabigatran In Non Valvular Atrial Fibrillation In ColombiaTriana, J. J. / Castañeda-Cardona, C. / Parada, L. / Rosselli, D. et al. | 2015
- A141
-
Comparative Cost-Effectiveness Analysis Of Catheter Directed Thrombolisys With Urokinase And Alteplase For Treatment Of Acute Peripheral Artery DiseaseKostyuk, A. / Akanov, A. / Almadiyeva, A. et al. | 2015
- A142
-
The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban In The Treatment of Acute Venous Thromboembolism In The UkJugrin, A. V. / Ustyugova, A. V. / Lamotte, M. / Sunderland, T. J. et al. | 2015
- A143
-
Real-World Outcomes of Acute Ischemic Stroke Patients In The Medicare PopulationWatson, C. / Burudpakdee, C. / Noone, J. / Seetasith, A. / Nyandege, A. et al. | 2015
- A144
-
Health Utilities Of Hypertensive Patients In VietnamNguyen, T. P. / C.C.M., S. / Postma, M. J. et al. | 2015
- A145
-
Patients In The Waiting List Of Bariatric Surgery In The Brazilian Public Sector Treatment Patterns And Health Outcomes: A Non-Interventional Single-Site Retrospective StudyJunqueira Junior, S. M. / Luque, A. / Cabra, H. A. / Andrade, P. C. / Oliveira, F. M. / Brasil, N. / Rasera, I. et al. | 2015
- A146
-
Agents Acting On Renin-Angiotensin System Usage In Croatia During The Fourteen-Year Period: Impact Of GenericsVitezic, D. / Kucan, M. / Mrsic Pelcic, J. / Vitezic, M. et al. | 2015
- A147
-
Influence Of Cost Sharing Differentials On Therapeutic Substitution And Medication Adherence: The Story Of Statins In 2006Li, P. / Schwartz, S. J. / Doshi, J. A. et al. | 2015
- A148
-
Annual Hospitalization Frequency For Patients With Heart Failure - A Comparison Between Commercial And Medicare Advantage PopulationPatel, H. / Maya, J. / Song, R. / Henk, H. J. / Kielhorn, A. et al. | 2015
- A149
-
The Burden Of Uncertainty In Emergency Room: The Case Of Chest PainAbbass, I. M. / Nassar, A. et al. | 2015
- A150
-
Pharmacoeconomics Research On Diabetes And Hypertension In India: A Study Based On Pubmed DatabaseDharmagadda, S. / Vooradi, S. / Mateti, U. V. et al. | 2015
- A151
-
Patterns of treatment modifications in newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation?Sonawane, K. B. / Qian, J. / Garza, K. B. / Wright, B. M. / Zeng, P. / Ganduglia Cazaban, C. M. / Hansen, R. A. et al. | 2015
- A152
-
Safety of Tofacitinib Compared to Biological Dmards In Rheumatoid Arthritis Patients With An Inadequate Response to Methotrexate: overview of Systematic ReviewsReyes, J. M. / Rodriguez, A. et al. | 2015
- A153
-
Incidence and Prognostic Factors for Contralateral Hip Fracture Among Hungarian Men over 60 YearsJuhász, K. / Gajdácsi, J. / Boncz, I. / Molics, B. / Sebestyén, A. et al. | 2015
- A154
-
Comparison of Disease Status and Outcomes of Patients With Rheumatoid Arthritis (Ra) Receiving Adalimumab or Etanercept Monotherapy In The United States (Us)Narayanan, S. / Lu, Y. / Hutchings, R. / Baynton, E. et al. | 2015
- A155
-
Use of Anti-osteoporosis Medications and Fracture Risk Among Elderly Patients With End-Stage Renal Disease: A Retrospective Cohort StudyLo, P. / Tsai, H. / Chao, C. / Peng, L. / Tsai, Y. / Chen, L. et al. | 2015
- A156
-
Relationship Of Sedentary Behavior With Qalys In Community Dwelling Adults With or At Risk for Knee OsteoarthritisPinto, D. / Song, J. / Chang, R. W. / Semanik, P. A. / Ehrlich-Jones, L. / Pellegrini, C. A. / Dunlop, D. D. et al. | 2015
- A157
-
Modeling of Societal Costs Under Different Treatment Schemes of Post-Stroke Spasticity In The Russian FederationYagudina, R. / Kulikov, A. / Ugrekhelidze, D. et al. | 2015
- A158
-
Costs Description of Rheumatoid Arthritis Treatment In Chile For Patients Who Have Failed To Conventional Synthetic DmardsDe la Puente, A. C. / Zaror, S. C. / Velasquez, Z. M. / Bustos Medina, L. / Gutierrez-Ardila, M. V. et al. | 2015
- A159
-
Patient Comorbdity Status And Incremental Total Hospitalization Costs In Elective Orthopedic ProceduresNichols, C. I. / Vose, J. G. et al. | 2015
- A160
-
The Economic Value of Tofacitinib 5 Mg Bid In The Treatment of Moderate To Severe Rheumatoid Arthritis: A Canadian AnalysisWoolcott, J. C. / Blackhouse, G. / Claxton, L. / Wallenstein, G. / Tran, T. / Goeree, R. / Taylor, M. / Moynagh, D. / Singh, A. et al. | 2015
- A161
-
What Is The Cost-Effective Bearing Surface Choice In Primary Total Hip ArthroplastyCarnes, K. J. / Odum, S. M. / Troyer, J. L. / Fehring, T. K. et al. | 2015
- A162
-
Cost-Effectiveness Analysis of Bisphosphonates for Secondary Prevention of Hip Fracture In TaiwanLo, P. / Wen, Y. / Tsai, Y. et al. | 2015
- A163
-
Impact of Rheumatoid Arthritis on Self-Reported Work Productivity, Disease Severity And Adherence In an Employed PopulationKamal, K. M. / Ghosh, S. / Koerner, P. / Miller, R. / Parekh, M. H. / Khairnar, R. et al. | 2015
- A164
-
Preferences for New Treatments Diminish In The Face of AmbiguityHarrison, M. / Bansback, N. et al. | 2015
- A165
-
Minimally Important Differences for Patient-Reported Outcomes Measurement Information System (Promis) Fatigue and Pain Interference ScoresBeaumont, J. L. / Fries, J. F. / Curtis, J. R. / Cella, D. / Yun, H. et al. | 2015
- A166
-
Patient, Health Plan And Community Factors Associated With Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis In Medicare Managed Care PlansMehta, S. / Teigland, C. / Pulungan, Z. / Kilgore, K. / Parente, A. / McClellan, M. / Jones, B. et al. | 2015
- A167
-
Comparison of Clinical Characteristics of Patients With Rheumatoid Arthritis (RA) Identified By Physicians As Potentially Suitable For Biosimilar Infliximab Versus Those Who Were Not Considered Biosimilar Infliximab Suitable In Europe (EU)Narayanan, S. / Lu, Y. / Hutchings, R. / Baskett, A. / Mentzer, S. et al. | 2015
- A168
-
Canadian Public Reimbursement of Subsequent Entry Biologics (Sebs) / BiosimilarsSiu, E. C. / Wyatt, G. et al. | 2015
- A169
-
Mortality And Readmission In Mechanically Ventilated Patients With PneumoniaHansen, R. N. / Black, D. J. / Joish, V. N. / Spilsbury-Cantalupo, M. / Sullivan, S. D. et al. | 2015
- A170
-
Real-World Observational Study of Association Between Statin Medications and Copd-Specific OutcomesAjmera, M. R. / Sambamoorthi, U. / Rust, G. / Pan, X. / Tworek, C. / Metzger, A. et al. | 2015
- A171
-
Factors Affecting 30-Day Hospital Readmissions Among Patients With Chronic Obstructive Pulmonary Disease (Copd)Kim, M. / Asche, C. V. / Tillis, W. et al. | 2015
- A172
-
Health-care costs of asthma are lower using mp29-02* vs. Sequential sprays for allergic rhinitisHarrow, B. / Sedaghat, A. R. / Munzel, U. / Tarr, A. / Gever, L. / Hofmeister, J. / Dufour, R. et al. | 2015
- A173
-
Cost-Effectiveness of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Canada, Sweden And The UkEklund, O. / Afzal, F. / Borgström, F. / Flavin, J. / Ternouth, A. / Baldwin, M. et al. | 2015
- A174
-
Assure-Csu Canadian Results: Assessing The Impact Of Chronic Spontaneous /Idiopathic Urticaria On Work Productivity And Indirect CostsSussman, G. / Lee, J. / Chiva-Razavi, S. / Chambenoit, O. / Hollis, K. / McBride, D. / Westlund, R. / Tian, H. / Balp, M. et al. | 2015
- A175
-
Treatment outcomes of Smear Positive Pulmonary TB Cases Registered In TB Patients In Quettaul Haq, N. / Baloch, W. / Iqbal, Q. / Naseem, A. / Bashir, S. et al. | 2015
- A176
-
Influence of Demographic Status on Outcomes In Copd Patients: A Prospective StudyA, S. / MK, U. / Mohan, M. K. / Rao, C. M. et al. | 2015
- A177
-
Adherence to Chronic Obstructive Pulmonary Disease Maintenance Medication Among Patients With CopdZhang, S. et al. | 2015
- A178
-
Rate of adverse event-related treatment changes and Healthcare costs associated with topical Rosacea treatmentWilliamson, T. / Kamalakar, R. / Ogbonnaya, A. / Kish, J. / Zagadailov, E. A. / Eaddy, M. / Kreilick, C. et al. | 2015
- A179
-
Study of Psychological stress and ACNE vulgaris among Pharmacy StudentsAb Hadi, H. / Awadh, A. et al. | 2015
- A180
-
Estimating the prevalence of Equine Recurrent Uveitis and the associated loss of value from visual impairment in Horses in the United StatesPoulsen Nautrup, B. / Van Vlaenderen, I. / Holland, R. / Donecker, J. M. et al. | 2015
- A181
-
Cost-effectiveness of Aflibercept in the treatment of Central Retinal Vein Occlusion in TurkeyTunalioglu, A. / Ozdemir, O. / Eldem, B. / Unlu, N. / Alp, M. N. / Saatci, A. O. / Ozmert, E. / Deger, C. / Asan, S. / Sumer, F. et al. | 2015
- A182
-
Economics in clinical guidelines: a cost-effectiveness analysis of repositioning strategies for the prevention of pressure UlcersMarsden, G. / Jones, K. / Neilson, J. / Stansby, G. / Collier, M. / Avital, L. et al. | 2015
- A183
-
Measuring Disease specific impact and symptoms among patients with Hidradenitis SuppurativaKimball, A. / Sundaram, M. / Mathias, A. / Foley, C. / Shields, A. et al. | 2015
- A184
-
Content development and refinement for a new Patient reported outcome measure for Psoriasis Treatment (PROMPT)Kitchen, H. / Cordingley, L. / Young, H. / Griffiths, C. E. / Bundy, C. et al. | 2015
- A185
-
Utilization, Price, and spending trends for Fluoroquinolones in the us Medicaid Program: 1991-2013Yue, X. / Guo, J. J. / Xia, Y. / Almalki, Z. S. / Wigle, P. R. et al. | 2015
- A186
-
The Budget Impact of Treatment Pathway Redesign In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph)Patel, S. / Garnham, A. / Nazir, J. et al. | 2015
- A187
-
Cost Of Illness And The Factors Affecting It In The Patients Of Chronic Kidney Disease At A Public Tertiary Care HospitalAhlawat, R. / Tiwari, P. / D’Cruz, S. et al. | 2015
- A188
-
Evaluation Of Medication Adherence Rate Among Hemodialysis Patients: A Multicentric Comparative StudyMateti, U. / Nagappa, A. / Atturi, R. et al. | 2015
- A189
-
Prioritization of Comparative Effectiveness Research Questions Based On Identification of The Most Relevant Outcomes To Improve Clinical Practice: An Application of Mcda To Dialysis Research PlanningKhoury, H. / Nesrallah, G. / Goetghebeur, M. et al. | 2015
- A190
-
Racial/Ethnicity Disparities In The Association Between Diabetes And Pancreatic Cancer In The Elderly Medicare PopulationLu, K. / Yuan, J. / Li, M. / Wu, J. et al. | 2015
- A191
-
The Burden of Aml Within theTurbeville, S. / Francis, K. M. / Behm, I. / Chiu, G. R. / Sanchez, H. / Morgan, J. / Yakovich, A. / Ward, R. / Hyare, P. et al. | 2015
- A192
-
Comparing The Efficacy Of Denosumab Versus Zoledronic Acid (Za) For Prevention Of Skeletal-Related Events (Sres): A Critical Appraisal Of Three Pivotal TrialsStrite, S. / Stuart, M. E. / Beckman, V. / Öhrling, K. et al. | 2015
- A193
-
Incidence And Prevalence Of Basal Cell Carcinoma In A Large United States Commercially Insured PopulationGoldenberg, G. / Karagiannis, T. S. / Palmer, J. B. / Lotya, J. / O’Neill, C. B. / Kisa, R. M. / Herrera, V. et al. | 2015
- A194
-
Overall survival in post-menopausal women with hr+/her2- metastatic breast cancer treated with 1st-line endocrine therapy vs. ChemotherapyVekeman, F. / Hao, Y. / Cheng, W. Y. / Fortier, J. / Robitaille, M. / Duh, M. S. et al. | 2015
- A195
-
Economic Impact of The Addition of Axitinib as a Second Line Treatment for Metastatic Renal cell Carcinoma in the Ecuatorian Public Heathcare SectorRosado-Buzzo, A. / Albuja, M. / Garcia-Molliendo, L. / Luna-Casas, G. et al. | 2015
- A196
-
Treatment Patterns and Costs Associated With Sunitinib and Pazopanib Treatment for Renal Cell Carcinoma: a Commercial Health Claims AnalysisHarnett, J. / MacLean, E. / Bhattacharyya, H. / Cisar, L. / Hoang, C. J. / Mardekian, J. et al. | 2015
- A197
-
Healthcare Resource utilization and Medical Care Cost Associated With New Bio-Surgical Hemostasis In ChinaMa, Y. / Gu, X. / Wu, J. / Yue, N. / Lyu, R. et al. | 2015
- A198
-
Systematic Review of Epidemiology and Burden of Pancreatic CancerAggarwal, S. / Topaloglu, H. / Kumar, S. et al. | 2015
- A199
-
Direct Medical Costs Of Her2 Positive Breast Cancer Management In Iran: A Claims Database And Data Mining AnalysisAnsaripour, A. / Zendehdel, K. / Uyl - de Groot, C. A. / NaemiSanatdost, A. / Redekop, W. K. et al. | 2015
- A200
-
Perceptions Of Biosimilar Monoclonal Antibodies Amongst Eu5 Budget HoldersGardiner, R. B. et al. | 2015
- A201
-
Cost – Efficacy Study for Ipilimumab in the Chilean MarketRovegno, M. / Llanos, C. / Galleguillos, S. / Garrido Lecca, S. et al. | 2015
- A202
-
Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination In Mainland ChinaGai, R. et al. | 2015
- A203
-
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In TurkeyErdal, E. / Sayman, H. / Turkmen, C. / Aral, F. / Yildiz, O. / Okutur, K. / Parali, E. / Deger, C. / Tunalioglu, A. / Sar, C. et al. | 2015
- A204
-
Cost-Effectiveness Of Multiplexed Predictive Biomarker Screening In Non-Small Cell Lung CancerRomanus, D. / Cardarella, S. / Cutler, D. / Landrum, M. B. / Lindeman, N. / Gazelle, G. S. et al. | 2015
- A205
-
Economic Evaluation of Transarterial Chemoembolization With Lipiodol Versus Drug Eluting Bead for the Treatment of Hepatocellular Carcinoma In Egyptian PatientsFouad, S. / Elsisi, G. / Elmahdawy, M. et al. | 2015
- A206
-
Hospital Utilization In Patients With Mantle Cell LymphomaBelk, K. / Craver, C. W. et al. | 2015
- A207
-
The Effectiveness of Carepak® Adherence Packaging In Increasing Lenalidomide Therapy DurationRice, G. / Nolan, R. / Grigorian, M. et al. | 2015
- A208
-
Using Fact Data to Predict Preference-Based Utility Measures For People With Malignant Melanoma: A Review of The EvidenceAra, R. / Paisley, S. / Robinson, A. A. / Azough, A. / Mensah, L. et al. | 2015
- A209
-
Inclusion of Patient-Reported Outcome Measures In Registered Clinical Trials: Evidence From Clinicaltrials.Gov (2007-2013)Vodicka, E. / Kim, K. / Devine, B. / Gnanasakthy, A. / Scoggins, J. / Patrick, D. L. et al. | 2015
- A210
-
Does the generic cancer outcome measure eortc qlq-c30 work in myelofibrosis?Mukuria, C. / Brazier, J. / Rafia, R. et al. | 2015
- A211
-
Quality of Life Domains Associated With ReadmissionHayran, M. / Yüce, D. / Hüseyin, B. / Esin, E. / Kilickap, S. / Erman, M. / Celik, I. et al. | 2015
- A212
-
Are biomarkers a big market access bonus? us and eu5 payer perspectives and prescribing patterns for key targeted non-small-cell lung cancer agentsCox, J. / Roberts, D. / Gheorghe, D. / Moore, R. et al. | 2015
- A213
-
Promoting market access through breakthrough therapy designation: can this accolade help convince payers and prescribers?Duval, A. / Cox, J. et al. | 2015
- A214
-
Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial DataMacaulay, R. et al. | 2015
- A215
-
Baseline characteristics of patients provided Cancer Care within a Novel Commercial Health Plan Cancer Care quality programWilley, V. / Quimbo, R. / Tunceli, O. / Mack, M. / Malin, J. et al. | 2015
- A216
-
Variations in primary treatment among Elderly Women with early stage Breast Cancer: associations with factors related to old age and Vulnerable Socio-DemographicsLeMasters, T. J. / Madhavan, S. S. / Sambamoorthi, U. / Kelly, K. / Hazard, H. / Long, D. et al. | 2015
- A217
-
The impact of Genomic testing on Chemotherapy use and medical spending in a commercially-insured population of Breast Cancer PatientsEpstein, A. J. / Wong, Y. / Mitra, N. / Vachani, A. / Hin, S. / Yang, L. / Smith-McLallen, A. / Armstrong, K. / Groeneveld, P. W. et al. | 2015
- A218
-
Comparison of expected Health impacts for Major Cancers:Integration of incidence rate and loss of quality-adjusted Life ExpectancyHung, M. / Lai, W. / Chen, H. H. / Su, W. / Wang, J. et al. | 2015
- A219
-
Barbec(EU)d Oncology market access – how BBQ pulled pork is similar to European P&R NegotiationsSwilling, N. / Altier, J. et al. | 2015
- A220
-
Oncology Drugs receiving breakthrough Therapy designation: clinical trial characteristics, Drug pricing, and Approval processPark, Y. / Vegesna, A. / Ray, D. / Tsang, Y. et al. | 2015
- A221
-
An evaluation of clinical remission and safety among Biologics for moderate-to-severe crohns disease: a Bayesian Network meta-analysisBounthavong, M. / Bae, Y. H. / Vanness, D. J. / Kazerooni, R. / Devine, B. et al. | 2015
- A222
-
Meta-analysis of Ultrasonic scalpel versus Electrocautery in Laparoscopic Cholecystectomy in ChinaYin, C. / Metz, L. et al. | 2015
- A223
-
Risk of Liver Transplant in treated vs. Untreated Hepatitis CEms, D. / Racsa, P. / Anderson, C. / Gregory, F. / Worley, K. et al. | 2015
- A224
-
A Cost-utility analysis of Biologics for moderate-to-severe Crohn’s disease: evidence synthesis using a Bayesian Network meta-analysisBounthavong, M. / Bae, Y. H. / Devine, B. / Veenstra, D. L. et al. | 2015
- A225
-
Cost effectiveness of Daclatasvir/Asunaprevir versus Peginterferon/Ribavirin and protease inhibitors for the treatment of Hepatitis C Genotype 1B in ChileVargas, C. / Espinoza, M. A. / Giglio, A. / Soza, A. et al. | 2015
- A226
-
Self-reported Health status of patients with Chronic Hepatitis B in ChinaLuo, N. / Zhang, M. / Zhang, S. / Shang, J. / Han, T. / Guo, Y. / Wang, X. / Liu, J. / Bo, Q. et al. | 2015
- A227
-
A Descriptive analysis of a Real-World Population with Chronic Hepatitis C (CHC) treated with Simeprevir (SMV)- and/or Sofosbuvir (SOF)-based regimens: findings from a us payer databaseForlenza, J. / Fortier, J. / Laliberté, F. / Lefebvre, P. / Tandon, N. et al. | 2015
- A228
-
Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus InfectionChan, P. / Chen, J. / Paes, B. / Mitchell, I. / Li, A. / Lanctôt, K. et al. | 2015
- A229
-
Assessing Outcomes With Ceftaroline Treatment Compared with Standard of Care among Hospitalized Patients With Complicated Skin And Skin-Structure Infections (Csssi)Karve, S. / Hackett, J. / Levinson, J. et al. | 2015
- A230
-
Relative Efficacy of Simeprevir (Smv) Versus Telaprevir (Tpv) In The Treatment of NaÏVe Genotype 1 Chronic Hepatitis C Patients, Based on Indirect Comparison Using Patient-Level Clinical Trial DataDiels, J. / Thilakarathne, P. / Van Sanden, S. / Sbarigia, U. / Mehnert, A. et al. | 2015
- A231
-
Pharmacoepidemiology of Clostridial collagenase ointment for the treatment of Pressure Ulcers In outpatient Care SettingsGilligan, A. M. / Waycaster, C. R. et al. | 2015
- A232
-
Comparing First- and Second-Season Palivizumab Prophylaxis In Patients with Hemodynamically Significant Congenital Heart Disease in the Caress Database (2005-2014)Li, A. / Paes, B. / Mitchell, I. / Lanctôt, K. et al. | 2015
- A233
-
Cost-Utility analysis of three types of Influenza Vaccines (Trivalent, Trivalent High dose and quadrivalent) in adults aged 65 and Older Under Universal Influenza Immunization Program (UIIP) In Ontario, CanadaCheng, X. / Roïz, J. et al. | 2015
- A234
-
Recent trends in Urgent Antibacterial Threat-Related Hospitalization In the USReese, E. S. / Kurosky, S. K. / Candrilli, S. et al. | 2015
- A235
-
Costs and Challenges Associated with Diagnosis and Treatment of Infections In Hospitalized Patients: A Retrospective us Electronic Health Database StudyDurtschi, A. J. / Khangulov, V. S. / Peyerl, F. W. / Sammy, Y. et al. | 2015
- A236
-
A Cost-Effectiveness analysis of Pre-Exposure Prophylaxis for Hiv: a Us Payer PerspectiveVaidya, N. / Campbell, J. D. et al. | 2015
- A237
-
Economic Impact of Simulation-Based Training (SBT) for Central Venous Catheter (CVC) InsertionAsche, C. V. / Barker, L. / Ren, J. / Kim, M. / Kirkness, C. S. / McGarvey, J. / Short, J. / Vozenilek, J. et al. | 2015
- A238
-
The Cost effectiveness of a Novel High Priced Combination Therapy for Hepatitis C In Treatment NaÏVe Genotype 1 Infected PatientsMcGinnis, J. J. / Hay, J. W. et al. | 2015
- A239
-
Systematic Review of Economic Evaluation Studies of Vaccines In ChinaWen, Y. / Pan, X. / Griffiths, U. K. / Pennington, M. / Yu, H. J. / Jit, M. et al. | 2015
- A240
-
Cost/Utility analysis of Pneumococcal Vaccinees Pcv13 Versus Ppsv23 In Adults over 18 Years old in chileBiagini Leandro, L. / Rojas Ruben, R. / Fuentealba Francisca, F. / Pezzani Marcela, M. et al. | 2015
- A241
-
Knowledge Gaps About Pneumonia in older Adults: Baseline Results from the Pharmacists’ Pneumonia Prevention ProjectSchafer, J. J. / Steele, D. / Marthol, M. M. / Harris, L. F. / Pizzi, L. T. et al. | 2015
- A242
-
Assessing the Impact of Pegylated-Interferon/Ribavirin Therapy Duration Versus Viral Response on Health-Related Quality of Life (Qol) Outcomes In Chronic Hepatitis C Virus (Hcv) Patients, Using Multivariate Mixed-Effects ModelingThilakarathne, P. / Van Sanden, S. / Diels, J. / Mehnert, A. et al. | 2015
- A243
-
Encouraging orphan designation for new ebola treatments – could this do more harm than good?Macaulay, R. et al. | 2015
- A244
-
Resource Utilization and costs associated with multi-drug Resistant acinetobacter Baumannii: a Systematic Review of The LiteratureSchmier, J. / Hulme-Lowe, C. / Klenk, J. / Sulham, K. et al. | 2015
- A245
-
Pneumococcal vaccination Coverage In adults with high-risk Conditions: Missed Opportunities ContinueYang, H. K. / Zhang, D. / Shao, C. / Grabenstein, J. et al. | 2015
- A246
-
Real-World Practice Patterns For The Treatment Of Complicated Skin And Skin Structure Infections In Europe: A Retrospective Database AnalysisSulham, K. / Fan, W. / Plent, S. et al. | 2015
- A247
-
Sentinel site active Surveillance of the safety of first-line Antiretroviral medicines in NamibiaMann, M. / Mengistu, A. / Gaeseb, J. / Sagwa, E. / Mazibuko, G. / Garrison, L. P. / Stergachis, A. et al. | 2015
- A248
-
Performance of two World Health Organization Dengue classifications in a Pediatric Cohort from ColombiaPinzón-Redondo, H. / Paternina-Caicedo, A. / Alvis-Guzman, N. / Diaz-Quijano, F. / Zarate-Vergara, A. / Barrios-Redondo, K. / De la Hoz-Restrepo, F. et al. | 2015
- A249
-
Predictors of Cigarette Smoking in Three Asian Countries: China India and TaiwanAlmogbel, Y. / Abughosh, S. / Essien, E. J. / Sansgiry, S. S. et al. | 2015
- A250
-
Burden of disease of Hepatitis C in ColombiaAlvis-Guzman, N. / Romero, M. / De la Hoz-Restrepo, F. et al. | 2015
- A251
-
Economic burden of adverse events associated with first line Metastatic Renal Cell Carcinoma (MRCC) treatment in public and Private Brazilian PerspectiveFerreira, C. N. / Santana, C. F. / Rufino, C. S. et al. | 2015
- A252
-
Common reasons for and associated costs of Pediatric inpatient admissions in the United StatesMeyers, J. / Candrilli, S. et al. | 2015
- A253
-
Cost of Colorectal Cancer in VietnamNguyen, T. / Phan, T. / Nguyen, T. T. et al. | 2015
- A254
-
Medical care costs of Chikungunya Virus infection in a Pediatric Population in ColombiaCastañeda-Orjuela, C. / Díaz-Jiménez, D. / Rodríguez-Castillo, L. / Paternina-Caicedo, A. / Pinzón-Redondo, H. / Alvis-Guzman, N. / De la Hoz-Restrepo, F. et al. | 2015
- A255
-
Estimating the cost of Pneumonia cases admitted at the internal medicine wards of a tertiary Government Hospital in the PhilippinesRivera, A. S. et al. | 2015
- A257
-
Cost-effectiveness of a Behavioral Psychosocial treatment integrated across Home and School for Pediatric ADHD-Inattentive typeTran, J. L. / Sheng, R. / Esonwune-Chukwudi, P. / Beaulieu, A. / McBurnett, K. / Pfiffner, L. J. / Wilson, L. et al. | 2015
- A258
-
Expected costs and Health outcomes for a Cohort of Albertans diagnosed with Hepatitis CThanh, N. X. / Jacobs, P. / Waye, A. / Tyrrell, D. L. / Misurski, D. et al. | 2015
- A259
-
Impact of Email refill reminders on medication adherence among patients with Chronic Diseases in a retail Community PharmacyTaitel, M. S. / Mu, Y. / Lou, Y. / Cannon, A. et al. | 2015
- A260
-
Impact of structured patient Education on quality of life of South Indian DiabeticsTalla, V. / Yellu, N. R. / Pippalla, S. R. / Rao, V. / Pattnaik, S. / Subudhi, S. / Budike, R. / Pandalaneni, A. et al. | 2015
- A261
-
HEALTH RELATED QUALITY OF LIFE AND HEALTH CARE RESOURCE USE BURDEN IN MIGRAINE WITH AND WITHOUT NAUSEAFlores, N. M. / Lee, L. K. / Gajria, K. / Pomerantz, D. / Gandhi, S. K. et al. | 2015
- A262
-
Geographic patterns of self-reported Lifetime Depression DiagnosisTobo, B. B. / Adjei Boakye, E. / Buchanan, P. et al. | 2015
- A263
-
Relative age in class and ADHD in School Children – Diagnosis and Medication patterns – Intra-Annual and Inter-Annual DisparityHoshen, M. B. / Benis, A. / Keyes, K. M. / Zoega, H. et al. | 2015
- A264
-
Healthcare resource use among Patients with congestive Heart failure in a Large Health OrganizationBash, L. D. / Weitzman, D. / Sharon, O. / Aviram-Paz, M. / Chodick, G. / Shalev, V. et al. | 2015
- A265
-
Prevalence and determinants of Low-Cost Generic Drug program use in the privately-insured Adult PopulationPauly, N. / Brown, J. et al. | 2015
- A266
-
Human Papillomavirus (HPV) Vaccination during well-Child visits in privately insured Males 9-21 years of age in the United States in 2012Zhang, D. / Huang, M. / Kulkarni, A. S. / Niccolai, L. M. et al. | 2015
- A267
-
The impact of Patient Centered Medical Home in a Managed Medicaid PopulationChu, L. et al. | 2015
- A268
-
Is visual impairement associated with increased Hospitalization? a retrospective Cohort study of community-dwelling medicare beneficiaresTsang, Y. / Tom, S. / Onukwugha, E. et al. | 2015
- A269
-
Cost study on Provincial General HospitalsGantugs, Y. / Otgonbayar, D. / Tsolmongerel, T. et al. | 2015
- A270
-
Colorectal Cancer (CRC) costs in the us: findings from the Medical Expenditure Panel Survey 2008-2012Haider, M. R. / Qureshi, Z. / Horner, R. / Xirasagar, S. / Khan, M. M. et al. | 2015
- A271
-
Characteristics of Drug Therapy problems and response rate in Telephonic comprehensive medication reviews provided to 2014 medicare part D BeneficiariesWong, J. et al. | 2015
- A272
-
Impact of case management Nurses on cancer Patients: a Systematic ReviewBregman, C. / Doutriaux, A. / Cognet, M. / Gauthier, A. / Pourcel, G. / Ferrari, C. / Viguier, J. et al. | 2015
- A273
-
Healthcare Burden of cervical cancer in a national Medicaid managed care populationJoshi, N. / Khanna, R. / Pace, P. et al. | 2015
- A274
-
Prevalence of Mental Health Disorders and access to care among children Enrolled in the mississippi medicaidNunna, S. / Shah, R. / Banahan, I. B. / Hardwick, S. P. / Clark, J. P. et al. | 2015
- A275
-
Quality and Implementation Barriers of Prevention of Mother to child transmission of hiv Program in Ethiopia: a cross sectional studyLegesse, B. et al. | 2015
- A276
-
Outpatient Follow-Up Visits After Hospital Discharge for Mental Illness and Implications for re-admissionsLin, I. / Muser, E. / Munsell, M. / Menzin, J. et al. | 2015
- A277
-
Comparative Study of The Influence of Biapenem and Meropenem on Valproic acid blood concentrationTang, L. et al. | 2015
- A278
-
Total Migraine freedom for breath powered intranasal delivery of 22 mg Sumatriptan Powder (Avp-825) Versus 100 mg oral sumatriptan from the compass study of acute treatment of MigraineHalker, R. / Tepper, S. / Siegert, S. / Wallick, C. et al. | 2015
- A279
-
“Number Needed to treat” analysis to Assess the comparative outcomes from Teriflunomide and dimethyl fumarate studies in relapsing multiple sclerosisLeist, T. / Montalban, X. / Miller, A. / Dive-Pouletty, C. / Freedman, M. et al. | 2015
- A280
-
Budget Impact of adding peginterferon beta-1a to the formulary for the treatment of relapsing forms of multiple SclerosisMauskopf, J. / Graham, J. / Fay-Azhar, M. / Kinter, E. et al. | 2015
- A281
-
A Comparison of Healthcare Resource utilization and associated costs in adults with generalized convulsive seizures (GCS)Li, X. / Barghout, V. / Wang, Z. et al. | 2015
- A282
-
A Retrospective Analysis of the Economic Burden Among Patients Diagnosed with Chronic Migraine using the Veterans Health Administration Medical dataMao, X. / Shrestha, S. / Baser, O. / Wang, L. et al. | 2015
- A283
-
Cost Effectiveness of Early Treatment of Parkinson’s Disease in MexicoMarquez, M. / Diaz, J. / Pizarro, M. / Ibarra, A. / Cervantes, A. / Rodríguez, M. / Soto, H. et al. | 2015
- A284
-
Skeletal Muscle activity and Resource tool for sporadic Inclusion body Myositis (Smart-Sibm): Characterization of Resource Utilization and Financial Burden Experienced By Sibm PatientsBarghout, V. / DeMuro, C. / Price, M. / Lewis, S. / Tseng, B. et al. | 2015
- A285
-
What are people willing to pay for whole genome sequencing information?Marshall, D. A. / Gonzalez, J. M. / Johnson, F. R. / Pugh, A. / MacDonald, K. V. / Douglas, M. P. / Phillips, K. A. et al. | 2015
- A286
-
Sex Differences In over-the-counter sleep aid use in older adultsGross, H. J. / O’Neill, G. / Toscani, M. / Chapnick, J. et al. | 2015
- A287
-
Quality of Life in neuromyelitis optica: a Systematic reviewLikhar, N. / Dang, A. et al. | 2015
- A288
-
Willingness-to-Pay for Newborn Genetic Testing for Spinal Muscular AtrophyLin, P. / Shi, J. / Yeh, W. / Neumann, P. J. et al. | 2015
- A289
-
Healthcare resource utilization associated with rescue Medication use in adult Patients With Seizure Clusters: a retrospective chart ReviewVazquez, B. / Sidovar, M. / Squillacote, D. / Wu, E. / Macaulay, D. / Sorg, R. / Guo, A. et al. | 2015
- A290
-
Oral disease modifying therapy for multiple sclerosis; is this the new normal?Johnson, B. H. et al. | 2015
- A291
-
A Review of intraoperative interventions to prevent staple line leaks and Bleeds during Bariatric Surgical ProceduresGhosh, S. K. / Roy, S. / Chekan, E. / Fegelman, E. et al. | 2015
- A292
-
Comparison of disease status and outcomes of Patients with Ankylosing Spondylitis (AS) receiving adalimumab or Etanercept Monotherapy in the United States (US)Narayanan, S. / Lu, Y. / Hutchings, R. / Graham, C. M. / Baynton, E. et al. | 2015
- A293
-
Second prospective, Pharmacoepidemiologic database analysis of Phentermine and Topiramate extended-release usage from a representative us sample of Older PatientsPeterson, C. A. / Steelman, X. / Varghese, S. T. et al. | 2015
- A294
-
Economic implications of increasing usage of Calcium-Free balanced crystalloid solutions (BAL) versus 0.9% saline for intravenous (IV) fluid Therapy in patients with Systemic Inflammatory Response Syndrome (SIRS) in us HospitalsMakhija, D. / Munson, S. / Khangulov, V. S. / Peyerl, F. W. / Paluszkiewicz, S. M. / Laplante, S. / Liu, F. X. et al. | 2015
- A295
-
Comparing the Economic burden of various Diseases from a Payer’s perspective in ChinaWang, B. C. / Chen, Y. / Furnback, W. / Yang, R. / Xie, L. et al. | 2015
- A296
-
Direct Healthcare Costs of Opioid Abuse in Patients prescribed immediate release Hydrocodone in the United StatesMichna, E. / Chitnis, A. / Paramore, C. / Holly, P. / Bell, J. A. / BenJoseph, R. et al. | 2015
- A297
-
Demonstrating the cost effectiveness of Movantik for the treatment of opioid induced constipation in Patients with inadequate response to Laxatives; a UK perspectiveLawson, R. / Vioix, H. / Mudunkotuwe, S. / King, F. / Goh, J. / Marsh, K. et al. | 2015
- A298
-
Cost-utility analysis of Pain Medications used to treat Adult Patients with Chronic Back Pain in the United StatesShah, D. / Anupindi, V. R. / Vaidya, V. et al. | 2015
- A299
-
Estimating Utility values for Polycythemia vera using patient-reported outcomes from the response trial and existing Mapping AlgorithmsThompson, M. / Pepper, A. N. / Côté, I. / Oliver, N. et al. | 2015
- A300
-
Ibrutinib for the treatment of Mantle Cell Lymphoma (MCL): evaluating the correlation between patient-reported outcomes and durability of response in a Phase 2 studyRule, S. / Goy, A. / Martin, P. / Ramchandren, R. / Alexeeva, J. / Popat, R. / Avivi, I. / Advani, R. / Le Gouill, S. / Horowitz, N. et al. | 2015
- A301
-
Pain Functional Impairment and Quality of Life (P-FIQ): an assessment of reliability of five patient reported outcome (PRO) instruments in Adult People with Hemophilia (PWH)Kempton, C. L. / Wang, M. / Recht, M. / Neff, A. / Shapiro, A. D. / Buckner, T. / Kulkarni, R. / Nugent, D. / Batt, K. / Wisniewski, T. et al. | 2015
- A302
-
Determining patterns of Opioid misuse and misprescribing in South CarolinaQureshi, Z. / Ball, S. / Horner, R. / Kreiner, P. / Lopez-Defede, A. / Probst, J. / Bennett, C. et al. | 2015
- A303
-
Dosing pattern analysis for Biologics in the treatment of Psoriasis in Canada: indication-specific information retrieved from Administrative Claims DatabaseGregory, V. / Liu, N. / Robertson, C. / Gerega, S. / Barbeau, M. / Budry, L. et al. | 2015
- A304
-
Canadian retrospective claims data analysis of Biologics switching and retention patterns in Psoriasis PatientsMillson, B. / Poulin-Costello, M. / Garces, K. et al. | 2015
- A305
-
Why ask if you know? Acmg’s potential errors in making Newborn screening (NBS) recommendations from using surveyed opinions for incidence scoring when actual data are availableAlgarni, M. / Almutairi, H. / Rittenhouse, B. et al. | 2015
- A306
-
Assessing the impact of varying threshold criteria for Opioid OverutilizationDurkin, M. / Moll, K. / Pasquale, M. K. / Amos, T. / Null, K. D. et al. | 2015
- A308
-
Research Presentations Financial Disclosure Statements| 2015
- A319
-
ISPOR 20th Annual International Meeting Research Abstracts Author Index| 2015
- i
-
Table of Contents| 2015
- I
-
Instructions for Authors| 2015
-
Does the use of efficacy or effectiveness evidence in cost-effectiveness analyses matter?Dilokthornsakul, P. / Chaiyakunapruk, N. / Campbell, J. D. et al. | 2015
-
Reimbursement Decision Landscape For Metastatic Breast Cancer Therapies: A Comparison Of Factors Leading To Favorable And Unfavorable Recommendations Across Leading Hta AgenciesBanerjee, P. / Gupta, J. / Kumar, P. / Kapoor, A. / Mazumder, D. et al. | 2015
-
Synthesis Of Multiple Types Of Survival Data Within A Weibull Proportional Hazards Meta-Analysis: Treatment Outcomes In Patients With Double Hit Lymphoma (DHL)Snedecor, S. J. / Howlett, C. / Mato, A. et al. | 2015
-
Cure Models: Accounting For Cured Patients In Economic EvaluationsOthus, M. / Bansal, A. / Koepl, L. / Wagner, S. / Ramsey, S. et al. | 2015
-
Iqwig Early Benefit Assessments Of Type 2 Diabetes TherapiesOehrlein, E. / Hanna, M. / Perfetto, E. et al. | 2015
-
Patients’ And Physicians’ Time Trade-Off Preferences For Adverse Outcomes Associated With Metastatic Colorectal Cancer TreatmentsMorlock, R. / Gonzalez, J. M. / Ogale, S. / Sommer, N. / Posner, J. / Grothey, A. et al. | 2015
-
Low-Molecular-Weight Heparin Treatment Of Deep-Vein Thrombosis: A Network Meta-AnalysisDiaz, J. P. / Soto Molina, H. / Marquez, M. / Escobar Juárez, Y. et al. | 2015
-
Reviewing Clinical Outcome Assessment Usage In Clinical Trials: Introducing The Cola MethodologyTrigg, A. / Kitchen, H. / Willgoss, T. G. / Meysner, S. / Humphrey, L. et al. | 2015
-
Innovation In The Development And Validation Of Clinical Outcome Assessments (Coa): An Exploration Of Patient-Cenetered Creative MethodologiesMeysner, S. / Willgoss, T. G. / Kitchen, H. / Trigg, A. / Humphrey, L. et al. | 2015
-
Comparing The Adoption Of Epro In Clinical Research To Emr In Clinical Practice – Why Clinical Practice Is Ahead Of Research With Technology UseRoss, J. / Holzbaur, E. / Rothrock, T. / Wade, M. et al. | 2015
-
Cost-Utility Evaluation Of Continuing Education For The Management Of Type 2 Diabetes Mellitus Users In Pernambuco – BrazilAquino, C. M. / Lima, R. C. / Bezerra, A. F. / Sousa, I. M. / Cesse, E. / Carvalho, E. M. / Fontbonne, A. et al. | 2015
-
Psychometric Validation Of Performance Outcomes (Perfos) For Use With Hip Fracture (Hf) PopulationsGentile, B. / Ballinger, R. S. / Doll, H. A. / Bush, E. N. et al. | 2015
-
Methodology Using Pharmacy And Medical Claims Data To Evaluate Real-World Outcomes And Costs Of Ivf Treatment In The UsCorvino, F. A. / Surinach, A. / Locklear, J. C. / Howe, A. M. / Hayward, B. / Mahony, M. C. et al. | 2015
-
Unified Database Creation Applied To Public Brazilian Health Information Systems From The Hospital, Outpatient And Mortality Information SystemsPereira, R. G. / Leal, G. S. / Silva, L. V. / Andrade, E. I. / Acurcio, F. d. / Cherchiglia, M. L. / Guerra Junior, A. A. et al. | 2015
-
Assessing The Relative Contribution To Changes In Quality-Adjusted Life Expectancy Associated With Hba1c, Weight And Hypoglycaemia Across Multiple Risk Equations With The Core Diabetes Model (Cdm)McEwan, P. / Evans, M. / Lamotte, M. / Foos, V. et al. | 2015
-
Development Of The Hyperphagia Questionnaire For Use In Prader-Willi Syndrome Clinical TrialsFehnel, S. E. / Brown, T. M. / Nelson, L. / Chen, A. / Kim, D. D. / Roof, E. / Dykens, E. M. et al. | 2015
-
Content Validity Of A Patient-Reported Outcome Instrument For Pancreatic CancerTurner-Bowker, D. M. / Paty, J. / Celeste Elash, C. A. / Hare, T. / Leopold, L. / Cline, J. / Ascoytia, C. et al. | 2015
-
Epidemiology of advanced Therapies for the treatment of Diabetic foot ulcers in outpatient care settingsGilligan, A. M. / Waycaster, C. R. et al. | 2015
-
Budget impact model of a Blood based proteomic classifier for Indeterminate Pulmonary NodulesAggarwal, J. / Goss, T. / Mathews, C. / Kearney, P. / Diette, G. et al. | 2015
-
Economic value of preventing central venous catheter sepsis infections with early cannulaton arteriovenous grafts (ECAVGS) compared to Non-EcavgsMohr, B. A. / Trovillion, P. J. et al. | 2015
-
Clinical and cost outcomes from different Hyaluronic Acid treatments in patients with Knee OsteoarthritisDasa, V. / DeKoven, M. / Lim, S. / Long, K. / Heeckt, P. et al. | 2015
-
A System dynamics model for the cost-effectiveness Evaluation of Bacterial whole-genome sequencing for monitoring outbreaks of clostridium difficileBuchanan-Hughes, A. M. / Agirrezabal, I. / Eddowes, L. A. / Luheshi, L. M. / Török, M. E. / Sagoo, G. S. et al. | 2015
-
Estimating the cost-effectiveness of left Atrial Appendage closure compared to warfarin for stroke prevention in Atrial FibrillationShih, V. / Devine, B. et al. | 2015
-
Evidence of a gap in care: utilization of Radiologic Diagnostic imaging in patients with and without implantable defibrillatorsNazarian, S. / Reynolds, M. R. / Ryan, M. P. / Wolff, S. D. / Mollenkopf, S. / Turakhia, M. P. et al. | 2015
-
Measuring function in cognitive impairment: a suggested taxonomy for characterizing assessment instrumentsUng, B. L. / Perfetto, E. M. / Tom, S. / Pickering, M. K. / Yang, K. / Higa, S. et al. | 2015
-
Battling fear: a potential key to improving Colorectal Cancer ScreeningQureshi, Z. / Lee, M. J. / Horner, R. / Bennett, C. et al. | 2015
-
Geographic variation in depression diagnosis among medicare beneficiaries with acute Myocardial InfarctionTang, Y. / Kauer, J. / Schroeder, M. / Wehby, G. / Doucette, W. / Brooks, J. et al. | 2015
-
Effect of Diabetes Education Program on Type 2 DiabetesYounis, M. et al. | 2015
-
Time Until Insulin Initiation for Canagliflozin (Cana) versus Dapagliflozin (Dapa) In dual and triple Therapy for type 2 diabetes mellitus (T2dm) In IrelandBacon, T. / Willis, M. / Johansen, P. / Neslusan, C. et al. | 2015
-
Direct Medical costs associated with diabetic Complications in Patients with Type 2 Diabetes in the US Versus South koreaChang, C. / Lee, S. / Kim, C. / Suh, D. et al. | 2015
-
A Health Economic Evaluation of the Edge Study Using the Ims Core Diabetes ModelMcEwan, P. / Evans, M. / Foos, V. / Paldánius, P. M. et al. | 2015
-
A Cost-effectiveness Analysis of Alogliptin In Comparison to SaxagliptinWingate, L. T. / Oishi, T. S. / Shubar Ali, N. S. et al. | 2015
-
Evaluating the Cost of Bringing People with type 2 Diabetes mellitus to multiple targets of Treatment In CanadaSkovgaard, R. / Ploug, U. J. / Hunt, B. / Valentine, W. J. et al. | 2015
-
Prescribing Pattern, Guideline Adherence and Diabetes Mellitus Management With Co-Morbidities: a Malaysian Hospital PerspectiveIqbal, M. Z. / Khan, A. H. / Sulaiman, S. A. / Iqbal, M. S. / Iqbal, M. W. et al. | 2015
-
A Multivariate analysis of Prescribing Information for Next Generation type 2 Diabetes treatmentsTaylor, D. / Martin, S. / Sjostedt, P. et al. | 2015
-
Literature review of the use of ICER thresholds in Healthcare decision-makingKaura, S. / Nanavaty, M. / Seetasith, A. / Nyandege, A. / Khan, Z. M. et al. | 2015
-
Coverage of Medical devices: is Medicare consistent with Private Payers?Chenoweth, M. D. / Chambers, J. / Thorat, T. / Neumann, P. J. et al. | 2015
-
Competition and strategic regulation in the Argentine Pharmaceutical Market. a comparative study of six Therapeutic classesMaceira, D. / Palacios, A. et al. | 2015
-
Assessing the availability of Drugs marketed in the US and SwitzerlandZeukeng, M. / Seoane-Vazquez, E. / Szeinbach, S. et al. | 2015
-
Factors associated with Electronic Health record implementation among Hospitals in Americal Hospital association annual survey databaseBhounsule, P. / Peterson, A. M. et al. | 2015
-
Impact of cost sharing on specialty Drug Utilization and outcomes: a review of the evidence and Future directionsDoshi, J. A. / Li, P. / Ladage, V. P. / Taylor, E. A. et al. | 2015
-
Chilean Valuation Of The Eq-5d Health StatesZarate, V. / Kind, P. et al. | 2015
-
Patient Registries In India – National Cancer Registry ProgramJanodia, M. / Udupa, N. et al. | 2015
-
Examining the fracture-related cost burden and healthcare resource utilization post-menopause in the u.s. Medicare populationXie, L. / Keshishian, A. / Du, J. / Baser, O. et al. | 2015
-
Add Back Therapy Use Among Endometriosis Patients Initiating Leuprolide Acetate (La) Therapy: Association With Improved Adherence And Lower Surgery Rates In A Cohort Of Commercially Insured WomenSoliman, A. / Bonafede, M. / Farr, A. / Castelli-Haley, J. / Winkel, C. et al. | 2015
-
Small Benefits Of Third Trimester Check-Up Among Pregnant Women Positively Screened For Thyroid DisordersBartakova, J. / Jiskra, J. et al. | 2015
-
Assessment Of Level Of Medication Adherence In Different Non-Communicable Chronic Diseases Patient In Quetta, Pakistan: Dose Disease Condition Produces Any Changeul Haq, N. / Shaheen, H. / Iqbal, Q. / Naseem, A. / Razaq, G. / Younis, M. / Bashir, S. et al. | 2015
-
Patient reported outcomes: are they relevant to u.s. Payers?Bayliss, M. / Hughes, T. et al. | 2015
-
Factors Impacting Personalized Medicine Test Adoption: Evaluating Patient Preferences And Willingness To PayCanestaro, W. / Regier, D. / Veenstra, D. / Lavallee, D. / Basu, A. / Carlson, J. et al. | 2015
-
Reduction in er visits of ADHD patients: effect of long and short-acting StimulantsYucel, A. / Patel, J. / Pise, M. N. et al. | 2015
-
The impact of alternative Antipsycontic Medications on the risk of adverse events in patients treated for Bipolar disordersJiang, Y. / Park, S. / McCombs, J. et al. | 2015
-
Antipsychotic use and Foster Care placement stability among youth with Attention-Deficit Hyperactivity/Disruptive Behavior DisordersTai, M. / dosReis, S. / Shaw, T. et al. | 2015
-
Prevalence of self-reported Adult ADHD Symptoms among University Students: a Multidisciplinary ComparisonShanbhag, P. P. / Nayak, R. et al. | 2015
-
Impact of Kentucky House bill 1 on concurrent prescribing of Opioid, Alprazolam, and CarisoprodolFreeman, P. R. / Troske, S. / Goodin, A. J. / Blumenschein, K. / Talbert, J. et al. | 2015
-
Relative Efficacy and Tolerability of Vortioxetine compared with selected Antidepressants in patients with Major depressive Disorder with an inadequate response to prior TherapyDiamand, F. / Painchault, C. / Brignone, M. et al. | 2015
-
Drug Use Among Seniors On Public Drug Programs In Canada, 2012Proulx, J. et al. | 2015
-
Efficacy And Safety Of Amlodipine And Bisoprolol In Hypertension Treatment: A Systematic ReviewFujii, R. K. / Restrepo, M. / Pepe, C. / Fernandes, R. A. / Haas, L. / Junqueira, M. et al. | 2015
-
A Descriptive Analysis of Patient Characteristics, Bleeding And Recurrence Risk Among U.S Veteran Patients Diagnosed With Venous ThromboembolismXie, L. / Du, J. / Kariburyo, M. F. / Baser, O. et al. | 2015
-
Hyperkalemia Is Highly Prevalent In Patients With Cardiorenal Comorbidities Compared To Patients Without These ComorbiditiesLatts, L. M. / Reaven, N. L. / Funk, S. E. / McGaughey, K. J. / Adamson, R. T. et al. | 2015
-
Concomitant Sleep Disorder Significantly Enhances The Risk Of Cardiovascular Disease In Patients With PsoriasisChiu, H. / Chiang, Y. / Hsieh, C. / Tsai, Y. / Huang, W. / Tsai, T. et al. | 2015
-
Cost Effectiveness Of Statins In Primary Prevention Of Coronary Heart Disease: A Systematic Review And Quality Assessment Of Economic Evidence To Elucidate Recent Trends In UsaBardia, A. / Garg, G. et al. | 2015
-
Economic Evaluation Of Dabigatran Etexilate For The Treatment Of Deep Venous Thromoembolism And Pulmonary EmbolismHuicochea-Bartelt, J. L. / Ortiz-Blas, L. A. / Herran, S. / Gay-Molina, J. / Robledo, J. L. et al. | 2015
-
Cost Effectiveness of Apixaban For Stroke Prevention In Non Valvular Atrial Fibrillation In The Ecuatorian Public Healthcare SectorRosado-Buzzo, A. / Albuja, M. / Garcia-Molliendo, L. / Luna-Casas, G. et al. | 2015
-
Cost Effectiveness of an Anticoagulant Clinic After Introduction Of Noacs For Stroke Prevention In Atrial Fibrillation Patients In the United StatesAlhazami, M. / Holdford, D. A. et al. | 2015
-
Implementation Of The American Diabetes Association’s Standards Of Medical Care: The Case Of Statin Utilization In The Elderly With DiabetesLi, M. / Lu, K. / Maxwell, W. D. / Schulz, R. M. et al. | 2015
-
Budget Impact Analysis of The Inclusion of Tofacitinib In The Public List of Reimbursement In The Treatment of Rheumatoid Arthritis After Inadequate Response To Methotrexate In ColombiaVargas-Valencia, J. / Prieto, V. A. / Jáuregui, E. / Fernandez-Avila, D. / Chalem-Choueka, M. R. / Vasquez, G. et al. | 2015
-
Generic Switch Evaluation of Celebrex® In Patients With Osteoarthritis (OA) Using A Retrospective Claims DatabaseJI, X. / Liu, S. / Solem, C. T. / Shelbaya, A. / Walker, C. / Cappelleri, J. C. / Gao, X. / Stephens, J. M. et al. | 2015
-
The Cost-Effectiveness of Meniscal Repair Versus Partial Meniscectomy: A Model-Based Projection of Clinical Outcomes And Costs In The United States Healthcare SystemFeeley, B. / Liu, S. / Garner, A. M. / Zhang, A. / Pietzsch, J. B. et al. | 2015
-
Comparative Risk of Transfusion And Incremental Total Hospitalization Cost Of Primary Unilateral, Bilateral, And Revision Total Knee Arthroplasty ProceduresNichols, C. I. / Vose, J. G. et al. | 2015
-
Cost-Effectiveness Analysis of Certolizumab, Etanercept, Golimumab And Tofacitinib for The Treatment of Moderately To Severely Active Rheumatoid ArthritisHan, X. / Hay, J. W. et al. | 2015
-
Patient-Reported Physical Function Outcome Measure for Adults With Fibrodysplasia Ossificans Progressiva: Intelligent Test Design Based on Promis Item BanksMattera, M. S. / Kaplan, F. S. / Pignolo, R. J. / Grogan, D. / Revicki, D. A. et al. | 2015
-
Outcomes Validation of The Ases, Dash, Eq5d, And Vr6d In A Population of Orthopedics Patients With Upper Extremity MorbidityVan Doren, B. A. / Odum, S. M. et al. | 2015
-
Out-of-Pocket Expenses for Copd Patients In A Third Level HospitalMartínez- Briseño, D. / Fernández-Plata, R. / García-Sancho, C. / Cano-Jiménez, D. / Sansores-Martínez, R. / Ramíres-Venegas, A. / Casas-Medina, G. et al. | 2015
-
Multimorbidity and Copd Medication Receipt Among Medicaid Beneficiaries With Newly-Diagnosed CopdAjmera, M. R. / Sambamoorthi, U. / Dwibedi, N. / Rust, G. et al. | 2015
-
Cost of Canalicular Laceration repair in different Hospital settings: a decision analysisCannon-Dang, E. / Murchison, A. P. / Bilyk, J. R. / Pizzi, L. T. et al. | 2015
-
Indirect treatment comparison of interventions for Neovascular (WET) age-related macular degeneration (WET AMD)Malcolm, W. A. / Hodgson, R. / Glanville, J. / Barata, T. / Fleetwood, K. et al. | 2015
-
Patient reported outcomes in Glaucoma a Systematic reviewAggarwal, S. / Topaloglu, H. / Kumar, S. et al. | 2015
-
Time And Motion Study For Rituximab Sc Vs Iv In Colombian Patients With Non-Hodgkin LymphomaSaenz Ariza, S. A. et al. | 2015
-
Adherence to Tamoxifen and Armoatase Inhibitors Among Women Enrolled In Medicaid ProgramKhanna, R. / Joshi, N. / Pace, P. et al. | 2015
-
Evauation of Corcordance Between Patient Reported Outcomes (Pros) and Clinician Reported outcomes (Cros) In Patients With Metastatic Brain DiseaseTaychakhoonavudh, S. / Lal, L. / Swint, J. et al. | 2015
-
Patients’ Groups And Advocacy In Oncology: Awareness, Support And Unmet NeedsHoltz, L. / Minowa, E. / Julian, G. et al. | 2015
-
The Expected Impact of Oncology Biosimilars In Brazil And Mexico: Payers and Oncologists Consider The cost-Effectiveness of These Cheaper AlternativesZevallos, S. / Ribeiro, A. / Cox, J. et al. | 2015
-
Priority Access for the Biggest – Variable Provincial Access to Oncology Drugs In CanadaMacaulay, R. / Surtel, A. et al. | 2015
-
Gender-Specific Differences In Risk for Cost-Related Medication Nonadherence Among Cancer SurvivorsLee, M. J. / Li, Y. / Khan, M. M. et al. | 2015
-
Pattern of Adjunctive Drug Utilization in oncology DepartmentGogineni, S. et al. | 2015
-
Identification and Characterization of Long Term Survival Population In Non-Small-Cell Lung Cancer Patients Treated With ImmunotherapiesLuaces, P. / Sanchez, L. / Viada, C. / Rodriguez, P. C. / Alvarez, M. / Fonte, C. / Muchene, L. / Shkedy, S. / Lage, A. et al. | 2015
-
Bone Pain, Skeletal Related Events and Opioid Use in Patients With Prostate Cancer And Bone MetastasesValderrama, A. / Eapen, S. / Hennessey, K. A. / Jones, C. / Wen, L. / Germino, J. / Duh, M. S. et al. | 2015
-
Hospital Cancer Burden In Argentina: Costs, Mortality And ReadmissionsInsua, J. et al. | 2015
-
Adjusting overall Survival Estimates for Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate CancerNaidoo, S. / Ivanescu, C. / Skaltsa, K. / Phung, D. / Holmstrom, S. / Latimer, N. et al. | 2015
-
Hypofractioned Radiotherapy In the Treatment of Early Breast Cancer: Systematic Review And Meta-AnalysisAndrade, T. R. / Segreto, H. / Segreto, R. / Nazario, A. / Fonseca, M. et al. | 2015
-
A Cost Comparison of Split-Dose Reduced-Volume oral Sulfate Solution (OSS) And Polyethylene Glycol With Electrolytes Solution (Peg-Els)Cleveland, M. / Yermakov, S. / Davis, M. / Campbell, R. / Huynh, L. / Farraye, F. / Yenikomshian, M. et al. | 2015
-
Hospital Utilization In Patients With Ebstein’s AnomalyCraver, C. W. / Belk, K. et al. | 2015
-
Health Care Utilization And Cost Associated With Radioiodine Refractory (Rai-R) Differentiated Thyroid Cancer (DTC)Abouzaid, S. / Li, X. / Rietschel, P. et al. | 2015
-
Costs Of Treating Skeletal-Related Events Among Prostate Cancer Patients With Bone Metastases In A Commercial Insured Population In The UsZhong, Y. / Yao, J. / Donga, P. / Bilir, S. P. / Valderrama, A. et al. | 2015
-
Indirect Costs Among Metastatic Breast Cancer Patients Receiving EribulinWan, Y. / Copher, R. / Corman, S. / Abouzaid, S. / Gao, X. et al. | 2015
-
Quality of evidence supporting inclusion of Pharmacogenomic biomarkers in product labels of fda approved Oncology TherapiesJha, R. / Gupta, J. / Kapoor, A. / Mazumder, D. et al. | 2015
-
Carbohydrate intake and Breast Cancer risk in African American and European American Women in the Women’s circle of Health StudyJohnson, N. M. / Bandera, E. et al. | 2015
-
Is there an impact of the Orphan designation in Oncology on market access in Europe?Boiziau, S. C. et al. | 2015
-
Treatment of acute Appendicitis in Germany: results of the analysis of a Health Insurance claims databaseLange, A. / Gosemann, J. / Zeidler, J. / Blaser, J. / Ure, B. M. / Lacher, M. et al. | 2015
-
Respiratory Related Hospitalizations In Premature Infants Prophylaxed With Palivizumab In the Canadian Registry of Palivizumab (Caress)Abraha, H. Y. / Li, A. / Paes, B. / Mitchell, I. / Lanctôt, K. et al. | 2015
-
Annual Incidence Rates of Herpes Zoster among an Immunocompetent Population In The United StatesJohnson, B. H. / Gatwood, J. / Palmer, L. A. / Lenhart, G. / Kawai, K. / Acosta, C. J. et al. | 2015
-
Anidulafungin in Comparison to Fluconazole, Amphotericin B Deoxycholate, Amphotericin b Liposomal, Caspofungin And Micafungin For The Treatment of Invasive Candidiasis Among Non-Neutropenicpatients Above 16 Years: Bayesian Mixed Treatment Comparison (Mtc)Diaz, J. A. / Huerfano, C. / Niño, C. P. / Alzate, J. P. / Urrego-Novoa, J. R. / Moreno, J. A. / Prieto, V. A. et al. | 2015
-
The impact of NCMS policies on inpatient Health Expenditure and its equality in Rural ChinaGuo, N. / Wang, J. / Shi, L. W. / Han, S. / Zhu, D. / Guan, X. D. et al. | 2015
-
Differences in Breast Cancer screening rates in medicare advantage non-dual eligible members, dual eligibles enrolled in special need plans and other Healthcare PlansPulungan, Z. / Teigland, C. / Mehta, S. / Parente, A. et al. | 2015
-
Medical resource Utilization of acute Myocardial infarction patients with readmission: a retrospective analysis of Hospitalization data from Beijing Medical Insurance databaseWen, L. / Wu, J. / Yang, L. et al. | 2015
-
Clinical and economic analysis of simple contact dermatitis due to Urinary incontinence and pressure Ulcers of immobilized patients with Urinary incontinenceVorobiev, A. / Vorobiev, P. / Krasnova, L. et al. | 2015
-
Direct cost of Hypothyroidism and its complications in UkraineVadziuk, I. et al. | 2015
-
Direct and indirect costs to Employers of recall following screening Mammography among Female Employees in the usBonafede, M. M. / Miller, J. D. / Huang, A. / Troeger, K. A. / Fajardo, L. et al. | 2015
-
Out-of-pocket medical costs for parents with Children with down Syndrome in the United StatesKageleiry, A. / Samuelson, D. / Duh, M. S. / Lefebvre, P. / DerSarkissian, M. / Campbell, J. Y. / Skotko, B. G. et al. | 2015
-
Remote monitoring strategies for patients with stable Heart failure: a systematic review and Network meta-analysisPandor, A. / Gomersall, T. / Stevens, J. W. / Wong, R. et al. | 2015
-
Pharmacotherapy Optimization plan for patients with type-2 Diabetes mellitus (T2DM) and Hypertension in a Chilean Healthcare setting: impact and outcomesSoto, A. / Avila, X. / Cordova, P. / Fernandez, P. / Lopez, M. / Villa, L. A. / Morales, F. et al. | 2015
-
Tuberculolis screening preferences of Healthcare workers in South Africa: a best-worst scaling study to analyze variation by OccupationO’Hara, N. N. / Roy, L. / O’Hara, L. M. / Spiegel, J. M. / Lynd, L. D. / FitzGerald, J. M. / Yassi, A. / Nophale, L. E. / Marra, C. A. et al. | 2015
-
Impact of Patient reported outcomes on Medication Therapy Management for High-Cost Specialty DrugsFeinberg, B. A. / Burruss, R. / Traurig, T. / Drenning, J. et al. | 2015
-
Is Pharmaceutical care effective for Improving Blood Pressure Control and medication adherence among Hypertensive Patients? a reviewEziyi, A. / Adunlin, G. et al. | 2015
-
Assessing a Physician visit for Hepatic Dysfunction based on database merging claims and Annual Health Checkup data in JapanIto, C. / Nishikino, R. / Onishi, Y. et al. | 2015
-
Disease-Specific Distribution of Health Care Quality Measures In the united statesNicholson, G. L. / Halbert, R. J. et al. | 2015
-
Measuring low-value health services using Health Insurance claims dataTong, J. / Kralewski, J. / Dowd, B. / Carlin, C. et al. | 2015
-
Patient Valuation of different approaches to mental health and Substance use disorder treatmentEpstein, A. J. / Barry, C. L. / Fiellin, D. A. / Busch, S. H. et al. | 2015
-
Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the USBin Sawad, A. / Seoane-Vazquez, E. / Rodriguez-Monguio, R. et al. | 2015
-
Out of Pocket Cost for Pediatric Epilepsy management: results from malaysian populationKashyap, M. / Bahari, B. et al. | 2015
-
Sleep Medication Users and their CharacteristicsAnupindi, V. R. / Shah, D. / Vaidya, V. et al. | 2015
-
Estimating the value of Whole Exome Sequencing for parents of Children with Rare Genetic DiseasesMarshall, D. A. / MacDonald, K. V. / Lopatina, E. / Mackenzie, A. / Hartley, T. / Boycott, K. et al. | 2015
-
Specificity and Sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: a Meta-AnalysisRuiz, R. / Castañeda-Cardona, C. / Ruiz-Patiño, A. / Rosselli, D. et al. | 2015
-
Use of Hydrocodone/Acetaminophen: prevalence and estimating Emergency Department visitsHatfield, M. D. / Fleming, M. L. et al. | 2015
-
Prevalence and Economic burden of prescription Opioid Misuse and abuse systematic reviewOderda, G. / Lake, J. / Rudell, K. / Roland, C. L. / Masters, E. et al. | 2015
-
The changing costs of caring for Hemophilia Patients in the U.S.: insurers’ and patients’ perspectivesEldar-Lissai, A. / Hou, Q. / Krishnan, S. et al. | 2015
-
Aprotinin free Hemostatic sealant to reduce Blood loss in Surgical Patients: a systematic reviewLuque, A. / Junqueira Junior, S. M. / Cabra, H. A. / Andrade, P. C. / Oliveira, F. M. et al. | 2015
-
Economic Evaluation Of Bst-Cargel As An Adjunct To Microfracture Versus Microfracture Alone In Knee Cartilage SurgeryFrappier, J. et al. | 2015
-
Coverage Limits On Blood Glucose Test Strip Reimbursement For Diabetics In Canada: Utilization Impact For Diabetic Patients In The Ontario Public Drug Program (OPDP)Bosnic, N. / Goodfield, J. M. / Robertson, C. M. / Zhang, Y. et al. | 2015
-
Long-Term Health Care Costs Among Adults With Type 2 Diabetes Initiating Dpp-4 InhibitorsFarr, A. M. / Sheehan, J. / Brouillette, M. / Smith, D. M. / Johnston, S. / Kalsekar, I. et al. | 2015
-
When The Literal Meaning Just Won’t Do - Cultural Adaptation Issues Resolved During The Linguistic Validation Of A Behavioural ScaleWilliams, H. / Oke, L. / Scharf, L. / Anderson, H. / Gergovich, B. et al. | 2015
-
Evaluating Content Validity Of Performance Outcomes (Perfos): Establishing The Patient-Relevance Of Three Perfos In Elective Total Hip Replacement (Ethr)Ballinger, R. S. / Kerr, C. / Bush, E. N. et al. | 2015
-
Inclusion Of Multiple Studies In Matching Adjusted Indirect Comparisons (Maic)Belger, M. / Brnabic, A. / Kadziola, Z. / Petto, H. / Faries, D. et al. | 2015
-
Methods And Context For The Production Of Rapid ReviewsKato, E. U. / Hartling, L. / Guise, J. M. et al. | 2015
-
Impact Of Single Risk Factor Changes On Long-Term Outcomes And Cost In A Type 2 Diabetes Modeling Study Contrasting Projections With Ukpds68, Swedish National Diabetes Registry And The Advance Risk EquationsMcEwan, P. / Lamotte, M. / Foos, V. et al. | 2015
-
Development Of A Database Of Published Regulatory Recommendations Concerning The Use Of Clinical Outcome Assessment (Coas) In Drug Development: Outcomes InsitePerret, C. / Roborel de Climens, A. et al. | 2015
-
Metastatic-Free Survival And Overall Survival In Prostate CancerLi, T. / Thompson, M. / Tran, D. et al. | 2015
-
Validity And Limitations Of The Longitudinal Patient Database France For Use In Pharmacoepidemiological And Pharmacoeconomics StudiesJouaville, S. L. / Miotti, H. / Coffin, G. / Sarfati, B. / Meihoc, A. et al. | 2015
-
A Bayesian Framework To Estimate The Cost Of Care For Renal Disease Patients With And Without A Usual Source Of Care ProviderZanwar, P. / Parthasarathy, M. / Damien, P. et al. | 2015
-
Developing Sf-6d-V2: Examining The Dimensionality Of The Sf-36 Using Large Multinational DatasetsMulhern, B. / Brazier, J. / Bjorner, J. B. et al. | 2015
-
Directly Eliciting Personal Utility Functions: A New Way To Value Health-Related Quality Of LifeShah, K. / Devlin, N. / Mulhern, B. / van Hout, B. et al. | 2015
-
Safety pen needle (SPN) devices in the actue care setting: an analysis of health resource utilization (HRU) in the United StatesDiMario, S. / Smallwood, C. / Chandran, A. / Saltiel-Berzin, R. et al. | 2015
-
A Model to explore the potential budget impact of a novel screening tool for the detection of subclinical rejection among Kidney Transplant PatientsInocencio, T. J. / Jaglinski, K. / Uchida, H. / Hughes, K. E. et al. | 2015
-
Budget impact and cost- effectiveness of an innovative Blood glucose measurement device using pattern alert technology in insulin-treated diabetics in the United StatesKrumreich, J. / Froehlich, N. / Schauf, M. / Drapkin, J. / Zoellner, Y. F. et al. | 2015
-
A Cost-effectiveness analysis of biomarker testing to target treatment to patients with mild cognitive impairment at increased risk of Alzheimer’s DiseaseMichaud, T. L. / Kuntz, K. et al. | 2015
-
Cost effectiveness of prescribing EVZIO for lay heroin overdose reversalHoldford, D. A. et al. | 2015
-
Diffusion of Ultrasound among Physicians treating patients with Rheumatoid Arthritis: 2002-2013Atzinger, C. / Schauer, D. / Wiggle, P. / Cavanaugh, T. / Kelton, C. / Guo, J. J. et al. | 2015
-
Health-related quality of life in patients treated with continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis in SingaporeYang, F. / Griva, K. / Lau, T. / Foo, M. W. / Mooppil, N. / Newman, S. P. / Vathsala, A. / Lee, E. / Chia, K. S. / Luo, N. et al. | 2015
-
Patient factors in the decision to delay total Knee ArthroplastyZhao, R. / Carlson, A. M. / Ilfeld, B. M. / Berend, K. R. / Stultz, M. R. et al. | 2015
-
Access to imported medical devices due to inflation and under funding of Argentinian Health sector in 2013Gilardino, R. / Koffsmon, A. L. / Cabra, H. A. et al. | 2015
-
Bayesian network Meta-Analysis (Nma) to Assess the relative Efficacy of Canagliflozin Monotherapy over 26 weeks In Patients with Type 2 Diabetes mellitus (T2dm)Schroeder, M. / Taieb, V. / Belhadi, D. / Seyla-Hammer, C. / Hemels, M. / Nielsen, A. T. et al. | 2015
-
Real-World adherence in Medicare Patients with type 2 Diabetes Mellitus (T2dm) for exenatide qw and Liraglutide qdTarr, A. / Nguyen, H. / Dufour, R. / Bullano, M. et al. | 2015
-
The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In SpainNielsen, A. T. / Pitcher, A. / Lovato, E. / Schubert, A. / Hemels, M. / Neslusan, C. / González, B. et al. | 2015
-
Evolution of the Market for oral Antidiabetic agents In Canada after Introduction of Dipeptidyl Peptidase-4 InhibitorsLavoie, L. / O’Neil, B. / Welner, S. et al. | 2015
-
Tracking the sponsoring Country of incorporation for new Drugs approved by the us FDA in the period 1980-2014: a trend analysisAlqahtani, S. S. / Rodriguez-Monguio, R. / Seoane-Vazquez, E. / Eguale, T. / Zeukeng, M. J. / Szeinbach, S. et al. | 2015
-
Key trends in Healthcare spending in Brazil in 2015Saggia, M. et al. | 2015
-
Trends in Budget impact analysis across Central Asian CountriesKostyuk, A. / Akanov, A. / Almadiyeva, A. et al. | 2015
-
How many Outpatient Surgery beds do we need?Wong, P. / Sommer, M. / Buhs, A. et al. | 2015
-
Trend analysis of G-BA decisions – what factors influence the Likelihood of recommendations?Hill, C. A. / Hill, D. / Marshall, J. D. / Harries, M. et al. | 2015
-
The difference between the maximum retail Price and tender Price: a comparative study on Brandname and Generic DrugsLiu, B. et al. | 2015
-
Practical problems of comparator selection to assess cost-effectiveness of New Drugs for reimbursement decision: a qualitative study in South KoreaKang, H. / Lee, H. / Cho, H. et al. | 2015
-
The effect of DRG-based performance- volume limit on the annual budget of the Clinical Centre of University of Pécs in HungaryEndrei, D. / Ágoston, I. / Csákvári, T. / Répásy, B. / Molics, B. / Danku, N. / Vajda, R. / Boncz, I. et al. | 2015
-
When is Health Economics and outcomes research evidence important to U.S. payers?Bajaj, P. S. / Willke, R. J. / Basu, A. / Sullivan, S. D. / Garrison, L. P. et al. | 2015
-
Evaluating the cost of Patient-centered Medical Home Transformation in small Primary care PracticesVegesna, A. / Lieberthal, R. D. / Payton, C. / Sarfaty, M. / Valko, G. et al. | 2015
-
Serious adverse Drug events reported to the Food and Drug Administration (FDA): analysis of the FDA adverse event reporting system (FAERS) 2006-2011 databaseSonawane, K. B. / Hansen, R. A. et al. | 2015
-
Trends In Use Of Health Economic Evidence For Developing Clinical GuidelinesAggarwal, S. / Kumar, S. / Topaloglu, H. et al. | 2015
-
A Systematic Quantitative Approach To Incorporating The Patient Perspective Into Health Technology Assessment Decision MakingGlase, K. M. / Walters, N. B. / Stephenson, T. M. / Vines, R. / Millman, S. / Rose, J. / Fifer, S. et al. | 2015
-
Analysis Of Ethical Theories And Principles Embedded In Holistic Mcda: A Primer To Ethics-Based Appraisal Of Value In HealthcareGoetghebeur, M. M. / Wagner, M. / Bond, K. / Hofmann, B. et al. | 2015
-
A Situation Analysis Of Health Policy And Health Technology Assessment In KazakhstanKostyuk, A. / Akanov, A. / Karp, L. / Nurgozhin, T. / Almadiyeva, A. et al. | 2015
-
Medication Adherence And Health Expenditure Comparison Of Atenolol And Metoprolol Immediate And Extended Release FormsAdhikari, K. / Hastings, T. / Vaidya, V. et al. | 2015
-
A Review Of The Effectiveness Of Visual Medication Tools In Boosting Patient Adherence And Reducing Hospital AdmissionsAnifowoshe, R. et al. | 2015
-
Prevalence And Predictor Of Antidepressants Use During Pregnancy In The Us: An Nhanes StudyPahuja, S. et al. | 2015
-
Trends in the prevalence of Dementia among the Medicare Beneficiaries: 2001-2010Lu, K. / Yuan, J. et al. | 2015
-
Change in Healthcare Utilization and costs in Patients with Major Depressive Disorder (MDD) initiating adjunctive Therapy with Second-Generation Antipsychotics (SGAS)Hagiwara, M. / Sun, S. X. / Moynahan, A. / Bornheimer, R. / Oster, G. et al. | 2015
-
Health resource use and cost analysis of Schizophrenia patients participating in a Randomized, Multicenter, Double-Blind, relapse prevention study of paliperidone palmitate 3-month formulationBenson, C. / Chirila, C. / Graham, J. / Radder, C. / Zheng, Q. / Woodruff, K. et al. | 2015
-
Medical cost-offset of once-monthly Paliperidone palmitate Monotherapy and adjunctive Therapy in 15-month trialJoshi, K. / Lin, J. / Lingohr-Smith, M. / Fu, D. J. et al. | 2015
-
Qualitative study of Patients’ preferences for Bipolar Depression TreatmentNg-Mak, D. S. / Poon, J. L. / Rajagopalan, K. / Kleinman, L. / Roberts, L. / Revicki, D. A. / Loebel, A. et al. | 2015
-
Health resource and Criminal Justice system costs for Young Clinical Trial Patients with Schizophrenia and prior Incareration by treatment failure statusKozma, C. / Muser, E. / Benson, C. / Mao, L. / Starr, H. L. / Alphs, L. et al. | 2015
-
Healthcare Utilization and costs among Adults with Major depressive Disorder treated with Vilazodone vs. other selective Serotonin Reuptake InhibitorsZhou, Z. / Sun, S. X. / Chopra, P. / Zhong, Y. / Totev, T. / Signorovitch, J. E. et al. | 2015
-
The relationship between Pseudoephedrine Sales and Clandestine Methamphetamine LabsTroske, S. / Freeman, P. R. / Goodin, A. J. / Blumenschein, K. / Talbert, J. et al. | 2015
-
Antipsychotic Utilization among Washington State dual EligiblesMurphy, S. M. / Kennedy, J. / McPherson, S. et al. | 2015
-
Resource Utilization and costs associated with off-label use of atypical Antipsychotics in a Community-Dwelling Adult Population: findings from the Medical Expenditure SurveyVarghese, D. / Carroll, N. V. et al. | 2015
-
Prevalence And Outcomes Of Global Vascular Hospital Admissions In ArgentinaInsua, J. et al. | 2015
-
Cost effectiveness of Antiglaucoma medicationsUsifoh, S. et al. | 2015
-
The Prevalence And Odds-Ratios Of Self-Reported Diagnosis Of Hypertension Among Us Adults By Racial/Ethnic Subgroups, Examining The Joint Effect Of Multiple Risk Factors: National Health Interview Survey, 2004 - 2013Godwin, O. / Brown, L. M. et al. | 2015
-
Annual Medication Cost Attributed To Each Kind Of Treatment Of Patients Subjected To Crmds ImplantationFanourgiakis, J. A. / Simantirakis, E. / Kanoupakis, E. / Chrysostomakis, S. / Maniadakis, N. / Kourlamba, G. / Vardas, P. et al. | 2015
-
Cost-Effectiveness Of Strategies For Management Of Deep Vein ThrombosisKostyuk, A. / Akanov, A. / Almadiyeva, A. et al. | 2015
-
Does Azilsartan Medoximil – Chlorthalidone Lower Risk of Coronary Heart Disease Than Olmesartan Medoximil – Hydrochlorthiazide In Patients With Essential Hypertension: A Cost-Effective AnalysisBhansali, A. / Sansgiry, S. S. et al. | 2015
-
Cost-Minimization Analysis of Tinzaparin Sodium Compared to Other Low-Molecular-Weight Heparins for Patients With Deep Venous ThrombosisDiaz, J. P. / Soto Molina, H. / Marquez, M. / Escobar Juárez, Y. et al. | 2015
-
Validation Of A Syndrome-Specific Instrument To Assess Angina Treated By Traditional Chinese Medicine (Tcm-Saq): The Ability To Detect ChangeZhang, H. Y. / Yu, L. / Lv, M. J. / Chen, Z. H. / Yang, G. L. et al. | 2015
-
Treatment With Some Bisphosphonates Is Associated With Aortic and Mitral Valve CalcificationAli, A. K. et al. | 2015